WO1994015462A1 - Antimicrobial compositions, process for preparing the same and use - Google Patents

Antimicrobial compositions, process for preparing the same and use Download PDF

Info

Publication number
WO1994015462A1
WO1994015462A1 PCT/US1993/000194 US9300194W WO9415462A1 WO 1994015462 A1 WO1994015462 A1 WO 1994015462A1 US 9300194 W US9300194 W US 9300194W WO 9415462 A1 WO9415462 A1 WO 9415462A1
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial
coating
composition
alumina
copper
Prior art date
Application number
PCT/US1993/000194
Other languages
French (fr)
Inventor
Howard Wayne Jacobson
Michael Heal Scholla
Sam Louis Samuels
Original Assignee
E.I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/742,963 priority Critical patent/US5180585A/en
Application filed by E.I. Du Pont De Nemours And Company filed Critical E.I. Du Pont De Nemours And Company
Priority to JP6516449A priority patent/JPH08505858A/en
Priority to EP93903055A priority patent/EP0677989B1/en
Priority to PCT/US1993/000194 priority patent/WO1994015462A1/en
Priority to DE69321139T priority patent/DE69321139T2/en
Priority to AU34412/93A priority patent/AU3441293A/en
Publication of WO1994015462A1 publication Critical patent/WO1994015462A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00Use of pretreated ingredients
    • C08K9/04Ingredients treated with organic substances
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • A01N59/20Copper
    • AHUMAN NECESSITIES
    • A46BRUSHWARE
    • A46DMANUFACTURE OF BRUSHES
    • A46D1/00Bristles; Selection of materials for bristles
    • AHUMAN NECESSITIES
    • A46BRUSHWARE
    • A46DMANUFACTURE OF BRUSHES
    • A46D1/00Bristles; Selection of materials for bristles
    • A46D1/006Antimicrobial, disinfectant bristles, handle, bristle-carrier or packaging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00Use of pretreated ingredients
    • C08K9/02Ingredients treated with inorganic substances
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09CTREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/36Compounds of titanium
    • C09C1/3607Titanium dioxide
    • C09C1/3653Treatment with inorganic compounds
    • C09C1/3661Coating
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09CTREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/36Compounds of titanium
    • C09C1/3607Titanium dioxide
    • C09C1/3669Treatment with low-molecular organic compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09CTREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C3/00Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
    • C09C3/08Treatment with low-molecular-weight non-polymer organic compounds
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • D01F1/103Agents inhibiting growth of microorganisms
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/60Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyamides
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/70Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyurethanes
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/10Particle morphology extending in one dimension, e.g. needle-like
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/20Particle morphology extending in two dimensions, e.g. plate-like
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/61Micrometer sized, i.e. from 1-100 micrometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/62Submicrometer sized, i.e. from 0.1-1 micrometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/64Nanometer sized, i.e. from 1-100 nanometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/80Particles consisting of a mixture of two or more inorganic phases
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/80Particles consisting of a mixture of two or more inorganic phases
    • C01P2004/82Particles consisting of a mixture of two or more inorganic phases two phases having the same anion, e.g. both oxidic phases
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/12Surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/20Powder free flowing behaviour
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/60Optical properties, e.g. expressed in CIELAB-values
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/80Compositional purity
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/90Other properties not specified above

Definitions

  • the invention is directed to an
  • antimicrobial powder composition comprising inorganic particles having a primary surface coating of a metal or metal compound and a secondary coating providing a protective function such as silica and alumina or alumina, and processes for enhancing dispersibililty.
  • a further aspect of the invention is
  • the invention also is directed to bifunctional powders, which can be used to deluster fibers as well as to provide antimicrobial properties.
  • Another aspect of the invention is directed to a method for controlling microorganisms and various applications based on the use of the aforementioned antimicrobial materials.
  • compositions selected from oxides of Ti, Mg, Al, Si, Ce, Hf, Nb and Ta, calcium hydroxyapatite and barium sulfate. It is disclosed that the compositions may be modified by the inclusion of other ingredients such as dispersion aids, and these compositions may be incorporated in polymeric materials in an amount of from 5-60% by weight of the composite.
  • the antimicrobial silver compound in contact with the polymer article may interact with it producing undesirable effects, such as darkening due to reduction to metallic silver.
  • aluminosilicates of either natural or synthetic origin, which have sites at which cationic exchange may occur.
  • articles having antimicrobial properties are made by incorporating the treated zeolites with the polymer or the zeolite can be mixed with the polymer and then treated with a solution of the desired antimicrobial metal ion.
  • the use of the zeolite particles in polymer articles is described in detail in U.S. 4,775,585, and, more specifically, U.S. 4,525,410 is directed to fiber applications.
  • zeolite powders tend to agglomerate and are inferior in dispersibility when mixed with resins.
  • U.S. 4,741,779 adds fine silica, dry or as a sol, to provide a zeolite powder which has high free-flowability and low agglomerating properties.
  • antimicrobial zeolite compositions are also addressed in J 01164722 which relates to the use of additives such as fatty acid salts to aid dispersion and
  • UV-light absorbers to prevent color development.
  • the antimicrobial additive be easily dispersible within the polymer matrix without any significant adverse effects on polymer properties. It is also desirable that the antimicrobial be effective in controlling
  • the antimicrobial component is in direct contact with the product matrix with which it may react, leading to deterioration in properties, development of coloring or staining and other undesirable features. The development of color occurs during the shaping
  • composition of the present invention meets this need.
  • One aspect of the invention relates to an antimicrobial composition
  • an antimicrobial composition comprising inorganic
  • particles having a first coating i.e., primary coating of a metal or metal compound, i.e.,
  • a secondary coating comprises a layer of silica, silicates, borosilicates, aluminosilicates, alumina or mixtures thereof of about 0.5 to 20 % by weight of the core material.
  • the secondary coating functions as a barrier between the antimicrobial particle and a polymer matrix in which it may be incorporated, minimizing interaction with the polymer. In the absence of such a barrier adverse interactions can occur between the polymer matrix and the antimicrobial component. This may result in undesirable coloring or staining of polymer articles and also in the deterioration of physical properties.
  • the secondary coating layer is believed to influence the rate at which the antimicrobial component diffuses from a dispersed particle into the polymer matrix.
  • the small residual porosity of the silica or alumina coating for example, also allows the antimicrobial component to diffuse through at a slow controlled rate thus extending the duration of the antimicrobial activity.
  • the ability to adjust the dispersibility of the particulate compositions of this invention both increases their use efficiency and improves the quality of the product.
  • the antimicrobial particles may further comprise a tertiary coating layer of a hydrous metal oxide, which is much less agglomerated and disperse readily in polymers.
  • a tertiary coating of hydrous alumina or magnesia will raise the isoelectric point of the composition.
  • the control of the isoelectric point between about 5.5 and about 9.5 is beneficial in facilitating the dispersion and/or flocculation of the particulate compositions during plant processing and in their end use
  • Dispersion aids may be incorporated either with the antimicrobial powders or in the process for incorporating them in polymers.
  • a further aspect of the invention is
  • Another aspect of the invention relates to a polymeric article and processes for producing the same. Products incorporating the particulate
  • composition of this invention have antimicrobial properties by virtue of the particulate antimicrobial compositions that are incorporated therein.
  • the particulate antimicrobial compositions of this invention have antimicrobial properties by virtue of the particulate antimicrobial compositions that are incorporated therein.
  • compositions of this invention may be employed in a variety of products such as paints, coatings, caulks, grouts, mortar, cements and masonry products and shaped polymeric articles including, but not limited to, films, membranes, fibers, and mono-filaments including but not limited to mono-filaments for brushes.
  • the compositions of this invention can be used to replace all or part of fillers and/or pigments normally used in the product. For example, if TiO2 is selected as the core material, then the resulting powder, when incorporated into a fiber, will deluster the fiber as well as confer antimicrobial activity.
  • the antimicrobial particulate compositions of this invention are particularly useful when
  • Yet another aspect of the invention relates to a method for controlling microorganisms and various applications based on the use of the aforementioned antimicrobial materials.
  • the invention relates to novel particulate antimicrobial powder compositions comprising inert inorganic particles having a first coating of a metal or metal compounds and a second coating layer of silica, silicates, borosilicates, aluminosilicates, alumina or mixtures thereof.
  • the inorganic particles i.e., core material may be any of the oxides of titanium, aluminum, zinc, copper; the sulfates of calcium, strontium, barium; zinc sulfide; copper sulfide; zeolites; mica; talc; kaolin; mullite or silica. Lead or mercury compounds are contemplated equivalent core material but may be undesirable due to toxicity levels. Titanium dioxide and barium sulfate are the preferred core material with titanium dioxide being most preferred. Either crystalline form, anatase or rutile titanium dioxide is suitable for use in the present invention.
  • the average diameter of the core material is between 0.01 and 100 microns, preferably in the range 0.1 to 5 microns. In general, core materials in the sub-micron size range are preferred, since the resulting
  • antimicrobial composition can be distributed more uniformly throughout a polymer matrix.
  • the first coating conferring antimicrobial properties may be metallic silver or copper or
  • the antimicrobial component may also be an alloy of silver with copper or zinc.
  • the antimicrobial component should release silver, copper or zinc ions at an effective level of antimicrobial activity, e.g., a minimum of 2 log reduction within 24 hours in a shake flask test, over a prolonged period, such as months or preferably years.
  • the amount of antimicrobial component on the core particle is in the range of 0.05 to 20% by weight, preferably 0.1 to 5% by weight based on the particle core material.
  • the core particles may also be optionally precoated with alumina in the amount of about 1 to 4 % to ensure good antimicrobial properties after precipitation of the antimicrobial components.
  • the secondary protective coating is selected from silica, silicates, borosilicates,
  • the secondary coating functions as a barrier between the antimicrobial particle and a polymer matrix in which it may be incorporated, minimizing interaction with the polymer.
  • secondary coating also is believed to influence the rate at which the antimicrobial component diffuses from a dispersed particle into the polymer matrix.
  • the secondary protective coating layer corresponds to 0.5 to 20% by weight based on the core material, and preferably, e.g., 1 to 5% by weight of silica or, e.g., 1 to 6% by weight of alumina in the coated particle composition. It will be appreciated by those skilled in the art that if fine particles of a core material are employed in carrying out the invention, the practitioner should assure total surface coverage of the first coated core material.
  • the protective layer of silica or alumina can be quite dense although it must be sufficiently porous to permit diffusion of the antimicrobial metal ions through the coating at a slow rate, while functioning as a barrier which limits interaction between the antimicrobial component and the polymeric matrix in which it is distributed. Silica is a preferred coating material because of the relative ease with which dense, uniform coatings can be obtained.
  • Silica-coated particles may have a low isoelectric point and may tend to be difficult to disperse in organic materials.
  • the isoelectric point represents the pH at which a particle surface carries zero electric charge. Control of the isoelectric point between 5.5 and 9.5 is beneficial in facilitating the dispersion and/or flocculation of the particulate compositions during plant processing and in their end use applications. Therefore, for particles coated with silica or related materials with a low
  • isoelectric point a tertiary coating of hydrous alumina or magnesia, or other metal oxide may be added to raise the isoelectric point.
  • hydrous oxides of Al, Mg, Zr and the rare earths may bring the isoelectric point into the range of 5.5 to 9.5.
  • Hydrous alumina typically as a mixture of boehmite (A1OOH) and amorphous alumina (AI 2 O 3 H 2 O)
  • Isoelectric points in a preferred range of 5.5 to 8.8 can readily be obtained with alumina coatings. For higher
  • Dispersion aids may be incorporated either with the antimicrobial powder composition or in the process for incorporating them in polymers to facilitate dispersion in end use applications.
  • alumina may be selected as the secondary protective coating and a tertiary coating may not be needed to adjust the isoelectric point.
  • the isoelectric point of the resulting powder typically will be in the preferred range.
  • the process for preparing the antimicrobial compositions of the invention comprises the steps of first forming a stirred aqueous suspension of the core material in which the concentration of solids is between 10 to about 50 weight percent.
  • the core material employed in the process consists of fine particles of an inorganic composition selected from a group comprising the oxides of Ti, Al, Zn and Cu, the sulfates of Ca, Sr and Ba, zeolite, mica, talc, kaolin or silica. These compositions are essentially
  • Titanium dioxide and barium sulfate are the preferred core materials for use in the process of the invention with titanium dioxide being most preferred.
  • the average particle size of the core material can extend over a wide range from 0.01 to 100 microns depending on the shape of the particle, although in most cases the range is 0.1 to 5 microns.
  • the particles can have a wide variety of shapes, e.g. equiaxial, acicular or platelet. Smaller size equiaxial shaped particles are preferred since they give a more uniform distribution of antimicrobial effectiveness when they are
  • the finely divided core material particles will exhibit a specific surface area in the range of from 0.1 to 100 m 2 /g. Best results are achieved when the core
  • material particles have a specific surface area of from 1 to 20 m 2 /g.
  • the antimicrobial components are formed by precipitation reactions conducted in the stirred aqueous suspension of core material so that the core particles become coated with the precipitated antimicrobial composition.
  • component is selected from a group comprising Ag, Ag 2 O, AgCl, AgBr, Agl, Cu, CuO, CU 2 O; CuS; ZnO; ZnS; ZnSiO 3 and their combinations such as Ag/CuO,
  • the concentrations and amounts of reactants used in applying the antimicrobial components to the core particles are such that the former amounts to between 0.05 and 20% by weight, preferably 0.1 to 5% by weight of the supporting core particle.
  • the antimicrobial metal constituent is added to the suspension as a water soluble salt such as a nitrate or acetate together with an appropriate water soluble reagent to precipitate the desired antimicrobial compound.
  • Ag 2 O is an effective antimicrobial agent and it can be precipitated by adding AgNO 3 to a stirred aqueous suspension of core particles while maintaining the pH in the range of 5 to 9.
  • Reagents used for this purpose are hydroxides of ammonia, alkali metals or alkali metal silicates.
  • water soluble reducing agents such as formaldehyde, hydrazine or sodium nitrate are used to reduce the cation to the metal.
  • the antimicrobial component comprises more than one species, such as Ag and ZnSiO 3 , individual species may be precipitated successively or concurrently depending upon the compatibility of the reagents used to precipitate the different species. The choice of reagents, order of precipitation and procedural conditions can be employed by one skilled in the art.
  • the next step in the process is the application of a secondary protective coating, for example, silica or alumina to the antimicrobial particles in the aqueous suspension.
  • a secondary protective coating for example, silica or alumina
  • active silica is added to the agitated aqueous suspension heated to a temperature between 60° and 90oC while maintaining the pH of the suspension in the range of 6 to 11.
  • Active silica a low molecular weight form of silica, such as silicic acid or polysilicic acid, may be added to the suspension, or formed in situ as by the continuous reaction of an acid with an alkali silicate. Potassium silicate is generally preferred since the potassium ion has little tendency to
  • the bulk commodity is also more stable, which is advantageous from the standpoint of shipping and storing.
  • the silica content of the coated composition is between 0.5 and 20% by weight and most commonly it is between 1 and 5% by weight.
  • the curing step consists of holding the slurry at temperatures between 60° and 90°C, preferably between 75° and 90°C, for from about one-half to two hours, preferably about one hour, while maintaining the pH of the agitated slurry between 6 and 7.5.
  • the antimicrobial particles may be coated with alumina. This is accomplished by the addition, to the agitated aqueous suspension of the antimicrobial particles heated to between 60° and 90°C, of an alkali aluminate solution or other soluble aluminum salt, e.g., aluminate nitrate while
  • Sodium aluminate is preferred, because it is
  • a solution such as Vining's Solution. It is desirable to increase the density of the amorphous alumina phase in the coating by the addition of polyvalent anions selected from the group consisting of sulfate, phosphate and citrate. As in the case of the silica coating a small residual porosity is necessary to allow the antimicrobial species to diffuse through the protective coating.
  • the alumina content of the coated composition is between 0.5 and 20% by weight and preferably between 1 and 6% by weight.
  • the concentration of polyvalent anion in the suspension is about 0.5% by weight based on the alumina used to coat the particles.
  • the product is then recovered as a dry powder, consisting of particles coated with silica, alumina or silica/alumina, by filtration or
  • a vacuum rotary-type filter is
  • washing can be carried out without removing the product from the filter. Washing is continued until the filtrate is quite free from soluble ions. The washed cake is then dried in an air or vacuum oven.
  • the product may be passed through a
  • micronizer with either heated air or superheated steam, preferably at temperatures below 350oC.
  • micronizing/dispersion aid could also be added prior to drying of the recovered and washed solids.
  • control of the isoelectric point between 5.5 and 9.5 is beneficial.
  • the isoelectric point of the particles can be adjusted within the range 5.5 to 8.8 by using alumina as the secondary or tertiary coating.
  • alumina as the secondary or tertiary coating.
  • silica or other low isoelectric point material for the protective coating.
  • a tertiary coating is desired to adjust the isoelectric point to the range of 5.5 to 9.5.
  • the higher isoelectric point improves the dispersibility of the antimicrobial composition in all systems, e.g., water systems.
  • the isoelectric point represents the pH at which the surface of the particles carries zero electric charge.
  • the isoelectric point is determined by measuring the electrophoretic mobility of the particles in a dilute suspension.
  • An automated electrokinetics analyzer such as the Pen Ken System 3000, manufactured by Pen Ken, Inc., Bedford Hills, N.Y. is used for this purpose. Measurements are made at different pH levels and by graphically plotting the results, the isoelectric point, i.e., the pH at which the Zeta potential is zero, can be determined.
  • An optional hydrous metal oxide tertiary outer layer is applied as a final coating process. A solution of a salt which contains the desired metal is added to the agitated aqueous suspension at a
  • Metals contemplated for use according to the invention are those whose hydrous oxides have high isoelectric points, i.e. in the range of 5.5 to 9.5.
  • the hydrous metal oxide is selected from the group consisting of alumina, magnesia, zirconia and rare earth metal oxides, with alumina, particularly boehmite A1OOH and amorphous alumina AI 2 O 3 H 2 O, and magnesia which are most preferred for reasons of ease of application, availability and economy.
  • alumina particularly boehmite A1OOH and amorphous alumina AI 2 O 3 H 2 O
  • magnesia which are most preferred for reasons of ease of application, availability and economy.
  • Sodium aluminate is a preferred source of aluminum
  • magnesium chloride is a preferred source of magnesium.
  • the use of alumina allows adjustments of the
  • the pH of the suspension is preferably maintained in the range of 8 to 8.5.
  • magnesium chloride is used, the pH is preferably maintained at about 9.
  • Other water soluble salts may be used according to the invention such as chlorides, nitrates, and acetates.
  • a strong alkali such as sodium hydroxide or potassium
  • hydroxide can be added to the aqueous suspension to maintain the pH within the desired range. If a basic salt is used as the source of metal, a strong acid, such as hydrochloric acid, can be added to the aqueous suspension to maintain the pH within the desired range. Coating can be accomplished at room temperature, but the best results are obtained when the temperature of the suspension is maintained in the range of from 60° to 90oC.
  • the product is recovered as a dry powder, comprising the core material having the antimicrobial agent and the hydrous metal oxide/silica or alumina coating using the procedures previously described. It has also been found to be advantageous, both from the standpoint of improving the rate of compounding antimicrobial compositions of the invention in polymer systems and of forming more uniform dispersions, to add dispersion aids to the powders. The benefit derived from the dispersion aid is greater in those powders wherein the particles have not been given a hydrous metal oxide coating. Dispersion aids which can be used effectively in this aspect of the
  • Dioctyl azelate is a preferred dispersion aid for the antimicrobial compositions of the
  • the amount of dispersion aid added to the antimicrobial powder is between 0.2 and 3% by weight with 0.5 to 1% being sufficient in most cases.
  • the dispersion aid is normally intimately mixed with the antimicrobial powder, in standard equipment such a "v" or ribbon blender, prior to the micronizing step.
  • a further aspect of this invention relates to polymer articles having antibacterial properties by virtue of particulate antimicrobial compositions being incorporated into the polymer matrix.
  • the particulate antimicrobial compositions of this invention may be employed in a variety of products such as paints, coatings, caulks, grouts, mortar, cement and masonary products and shaped polymeric articles including, but not limited to, films, membranes, fibers and
  • mono-filament including but not limited to
  • the antimicrobial powders that are made by the above processes can be any antimicrobial powders that are made by the above processes.
  • the organic polymers from which the articles are fabricated include synthetic, natural and semi- synthetic organic polymers.
  • Examples of polymers that can be used to practice this invention include, but are not limited to, aliphatic and aromatic polyesters, including polyethylene terephthalate, polybutylene terephthalate, polyethylene isophthalate,
  • polyhexamethylene terephthalate polylactic acid, polyglycolic acid, and liquid crystalline polymers for high performance resins and fibers
  • polyester block copolymers polyethylene terephthalate, polylactic acid, polyglycolic acid, and liquid crystalline polymers for high performance resins and fibers
  • polyester block copolymers polyethylene terephthalate, polylactic acid, polyglycolic acid, and liquid crystalline polymers for high performance resins and fibers
  • polyester block copolymers polymers for high performance resins and fibers
  • aliphatic and aromatic polyamides polyhexamethylene terephthalate, polylactic acid, polyglycolic acid, and liquid crystalline polymers for high performance resins and fibers
  • nylon 6 nylon 66
  • nylon 610 nylon 11
  • nylon 1212 nylon 1212
  • copolymerised polyamides including polyethylene, polypropylene, and copolymers thereof; vinyl polymers, including polystyrene,
  • polyurethane elastomers spandex or elastane elastomers
  • polyethers including polyacetals
  • polyketones polyetherether ketone (PEEK), polyether ketoneketone (PEKK); polyether and polyester block polymers; polysulfides; polysulfones; polysiloxanes such as polydimethyl siloxane; polycarbonates;
  • thermosetting synthetic polymers such as
  • polyesterurethane polyetherurethane
  • polyetherurethaneurea polyesterurethaneurea
  • natural polymers such as cellulosics, cotton and wool
  • regenerated or semi-synthetic polymers such as rayon, cuprammonium rayon, acetate rayon, triacetate rayon, reconstituted silk and polysaccharides.
  • This group includes reasonable copolymers, terpolymers and blends of many of the species listed.
  • Spandex is defined herein to refer to a fiber or filament made from a long chain synthetic polymer that comprises at least 85% by weight of a segmented polyurethane.
  • the polymer articles of this invention can be, for example, in the shape of films, fibers, powders, granules or articles made therefrom such as containers, pipes and monofilaments for brushes.
  • the moulded article preferably has a large surface area.
  • a polymer article of the invention having antimicrobial properties is comprised of at least one of the aforementioned particulate antimicrobial compositions and at least one organic polymer.
  • the antimicrobial composition accounts for 0.1 to 60% by weight, preferably 0.1 to 15% by weight of the polymer article, and most preferably 0.3 to 2% weight of the polymer article.
  • the antimicrobial composition is incorporated in an amount less than about 0.1% by weight, the polymer article has insufficient antimicrobial activity for any useful applications.
  • the polymer article has insufficient antimicrobial activity for any useful applications.
  • antimicrobial activity of the polymer article and the physical properties of the polymer article start to show some deterioration. This limits the usefulness of the article. Furthermore, the incorporation of high levels of the antimicrobial composition is undesirable from an economic standpoint and because of undesirable effects on the properties of the composite.
  • preferred upper level for the antimicrobial component is about 15% weight below which level there is an optimum combination of antimicrobial activity, polymer article properties and cost-efficiency.
  • the particle size of the antimicrobial powder may be in the range of a few microns to tens of microns or even up to a hundred microns.
  • a particle size of 5 microns down to a one hundredth of a micron (ten nanometers), especially less than 2 microns is commonly employed for fibers intended for use in clothing.
  • the polymer articles according to the present invention may contain other additives as well as antimicrobial compositions. They may contain, for example, polymerization catalysts, stabilizers, delustering agents, optical whitening agents, organic or inorganic pigments, inorganic fillers, plasticisers and so on. It is also possible that the antimicrobial particles themselves can fulfill a dual role and provide the benefits of some of the aforementioned additives.
  • compositions of this invention can be used to replace all or part of fillers and/or pigments normally used in the product.
  • This invention also relates to bifunctional powders, which can be used to deluster polymeric fibers as well as to provide antimicrobial properties. For example, if TiO 2 is selected as the core particle, then the resulting powder, when incorporated into a fiber, will deluster the fiber as well as confer antimicrobial activity.
  • the antimicrobial particulate compositions of this invention are particularly useful when
  • antimicrobial powders may be added to a monomer or to an intermediate product prior to polymerization.
  • Precoating of antimicrobial particles with polymer greatly facilitates incorporation of the particles in the bulk polymer. This may be done, for example, by slurrying the antimicrobial powder with a solution of the polymer, then removing the solvent by drying. About 1 to 5% by weight of polymer based on the coated powder is suitable for this purpose.
  • the polymer articles are fabricated from the antimicrobial polymer compositions and mixtures of them using well known procedures. These include, but are not limited to, for example, coating, molding, extruding, spinning and melt blowing. If it is desirable to have the antimicrobial component
  • a tacky surface can be produced by dipping the article in an appropriate solvent. On cooling the article the surface sets with the
  • Dispersion aids may also be incorporated in the process of forming the polymer carrier matrices or articles.
  • Process for Controlling Microorganisms The present invention also provides processes for controlling microorganisms using the antimicrobial materials of the invention.
  • Microorganisms can be controlled in a variety of media by contacting an effective amount of the antimicrobial material with a microorganism.
  • a convenient medium is an aqueous medium although a gaseous medium would behave similarly.
  • antimicrobial material would also be expected to control microorganisms.
  • the antimicrobial material of the present invention controls a broad spectrum of microorganisms.
  • the material has been found to be useful in
  • the antimicrobial material would also be expected to control algae, protozoa, viroids and prions in a similar manner.
  • bacteria By the term “bacteria” is meant eubacteria and archaebacteria. Eubacteria include fermicutes, gracilicutes and ternicutes. Gracilicutes include gram-negative, facultatively anaerobic rods.
  • Gram-negative, facultatively anaerobic rods include Enterobacteriaceae.
  • Enterobacteriaceae include
  • Klebsiella and Escherichia Klebsiella include
  • Klebsiella pneumoniae and Escherichia include
  • Fermicutes include the group gram-positive cocci, and the group endospore-forming rods and cocci.
  • Gram-positive cocci include
  • Micrococcaceae include Staphylococcus and Staphylococcus includes Staphylococcus aureus.
  • Endospore-forming rods and cocci include Bacillaceae.
  • Bacillaceae includes Bacillus which includes Bacillus circulans. All references herein to bacteria are in accordance with Bergey's Manual of Systematic
  • Myceteae includes Amastigomycota.
  • Amastigomycota include Deuteromycotina which includes Deuteromycetes.
  • Deuteromycetes include Aspergillis and Candida.
  • Aspergillis includes Aspergillis niger and Candida includes Candida albicans.
  • virus includes bacteriophage.
  • Bacteriophage includes T-series bacteriophage which includes T-even bacteriophage such as bacteriophage T4.
  • suitable applications comprising the antimicrobial articles and materials of the present invention include medical applications, such as, melt blown antimicrobial fibers for sterile filters dental devices, food wrap, floor coverings, such as carpet backings, textile applications such a ⁇ sportswear, intimate apparel, shoe linings, socks, undergarments and the like and coatings. More
  • medical applications such as, melt blown antimicrobial fibers for sterile filters dental devices, food wrap, floor coverings, such as carpet backings, textile applications such a ⁇ sportswear, intimate apparel, shoe linings, socks, undergarments and the like and coatings. More
  • examples of medical devices include wound closure devices, such as those sutures which are generally described in "Gore-Tex” Suture Bulletins, W.L. Gore & Assoc, Inc. (1986).
  • wound closure devices such as those sutures which are generally described in "Gore-Tex” Suture Bulletins, W.L. Gore & Assoc, Inc. (1986).
  • devices for purifying or sterilizing aqueous solutions include those which are generally described in Gelman Sciences Process Microfiltration Catalog, (April 1986).
  • examples of devices for purifying or sterilizing a gas include those which are generally described in "Nonwovens in Filtration (1987)
  • catheters include those generally described in “MEDSPEC 1989,” Medical Device Register, Inc., (1989).
  • suitable devices for storing, transporting or dispensing sterile solutions, devices for controlling odors, wound dressings and garments such as gowns and masks are generally
  • melt spinning For polymers which are stable in a melt and whose melt viscosity is not too high (e.g., nylon 6,6) melt spinning is the preferred method. In continuous operation, injection of the antimicrobial particulate just prior to spinning would be typical.
  • press melt spinning allows one to produce very small samples of fiber for evaluation.
  • the polymer is ground to a powder (typically until it will pass through a 100 mesh screen) and mixed with the dry powder additive at the desired concentration (1% by weight for example).
  • the mixture is dried at >70oC under vacuum overnight and is then compression molded into a cylindrical plug at the appropriate molding temperature for the type of polymer being used.
  • the plug is removed from the mold and placed in a fiber spinning unit.
  • the polymer plug is melted and extruded through a spinneret into filaments which can then be drawn and wound up on collection bobbins for antimicrobial testing.
  • the antimicrobial particulate is dispersed (at the desired
  • Nylon 66 - dead bright nylon 66 powder 46 HRV was admixed with the indicated additives and melt spun into fibers.
  • Polyethylene - high density polyethylene (0.85 MI) was admixed with the indicated additives and flash spun from solution in difluorochloromethane to produce a plexifilamentary web for testing.
  • Polyethylene terephthalate - dead bright polyethylene terephthalate powder (21.4 HRV) was admixed with the indicated additives and melt spun into fibers.
  • Segmented polyurethane urea copolymer - the indicated additives were admixed to dimethylacetamide solutions of segmented polyurethane-urea copolymer containing a polyester soft segment or other soft segments. These solutions were either cast into films by solvent evaporation or wet spun into an aqueous coagulation bath to produce fibers for evaluation of antimicrobial activity.
  • Polyethylene bottles (60 ml) or sterile polystyrene centrifuge tubes (50 ml) are cleaned by rinsing with a 50/50 (V/V) nitric acid/deionized water solution. Following the nitric acid rinse, the bottles are rinsed several times with deionized water to ensure complete removal of the acid.
  • 50 ml of either deionized water or physiological saline (0.8%) 0.2 gm of neat test sample is then added, shaken briefly by hand and the 0.4% dispersion allowed to sit at ambient
  • the dispersion is filtered through a sterile 0.22 micron filter containing a cellulose acetate or cellulose nitrate membrane and sterile storage bottle and cap.
  • the aqueous leachate is then analyzed for trace metals via either Inductively Coupled
  • ICP-AES Plasma-Atomic Emission Spectroscopy
  • AA Flame Atomic Absorption
  • Prescouring was done at 71oC for 15 minutes using 0.25 g/1 each of Merpol DA and TSPP. Dyeing was done near the boil (99oC) for 1 hour and at pH 6 using leveling acid dyes and no UV inhibitors. Samples were then whiz dried. Aliquots of scour and dye baths were retained for heavy metal analysis.
  • AATTCC test method 150-1987 with the exception of using a different type and less amount of detergent, i.e., used 30 +/-5 g of Tide instead of 90 +/- 0.1 g of AATCC standard detergent 124.
  • Samples were tumble dried at 68-71°C in a Kenmore dryer (Model 95018502). All samples were washed 20 times with drying after each wash.
  • Antimicrobial activity was measured using the Shake Flask Test described generally in U.S.
  • the Shake Flask Test requires the test material to be in a form having a high surface area to weight ratio. Articles having the form of powders, fibers, and thin films have proven to be acceptable.
  • the bacterial inoculum for the Shake Flask Test was prepared by transferring 2.0 ml of an
  • This inoculum was then placed into sterile, disposable 250 ml Erlenmeyer flasks (Corning Glass Co., Corning, NY) containing 0.75 g of the material produced by the process of this invention or a
  • Each flask contained a known concentration of bacteria in a final volume of 75 ml phosphate buffer.
  • the initial concentration of bacteria used in the various examples was determined by serial dilution of the inoculum (0.2 mM Phosphate buffer, pH 7) and plating in triplicate on Trypticase Soy Agar (TSA) plates (sold commercially by BBL, Cockeysville, MD). The flasks were shaken on a Burrell wrist action shaker (Burrell Corp., Pittsburgh, PA). A 1.2 ml aliquot was removed from each flask after shaking for 1 hour (or other appropriate time interval as
  • Duplicate petri plates containing TSA were inoculated via spread plating with 0.1 ml each of the sample. The remaining 1.0 ml was serial diluted and plated in duplicate. The TSA plates were
  • Antimicrobial activity was determined by the formulas:
  • Ct concentration of bacteria (cfu/ml) in test flask at time t (one is added to the number to avoid calculating the log of zero),
  • CFt concentration of bacteria (cfu/ml) in control flask at time t
  • cfu/ml colony forming units per milliliter.
  • the organic polymer was tested substantially free of fiber finish.
  • test sample was weighed and added to the initial test tube in the series. This was vortexed several times to ensure a homogeneous mixture and serial dilutions (10 fold) performed.
  • the test tubes were shaken at 200 rpm at 37oC for 24 hours. After 24 hours, a sample was removed from each tube via an inoculationg loop (1 ul volume) and streaked onto the surface of a TSA plate. Plates were incubated for 24 hours at 37°C. Antimicrobial activity was evaluated by visually determining the number of colonies in the initial streak across the agar plate. A "+" rating was assigned to plates having growth. A "-" rating represents plates without any colonies. The MIC was based upon the minimum concentration of test compound which resulted in no microbial growth on the plate.
  • This example describes the preparation of a titanium dioxide (TiO 2 ) pigment powder coated
  • the product was a white powder readily dispersable in organic polymer systems and providing them with antimicrobial properties.
  • the equipment consisted of a five gallon polyethylene container equipped with a paddle stirrer, burettes to introduce solutions of reactants and a pH probe.
  • the container was mounted on a heating plate.
  • Solutions were then prepared, consisting of 20g ZnCl 2 (J.T.Baker, Reagent Grade), in 100 ml water and 625 g K 2 SiO 3 (Philadelphia Quartz, #6 KaSil; 25 weight percent SiO 2 ), diluted to 1000 ml with water. 93.75 ml of the ZnCl 2 solution and 250 ml of K 2 SiO 3 solution were added concurrently at a uniform rate to the stirred slurry over a 30 minute period,
  • the slurry was then cooled to 75oC and the pH adjusted to 8.2 with HCl.
  • 300 ml of Vinings solution NaAl(OH) 4 (Stanbach-Vinings Corp. 0.385g AI 2 O 3 /ml), was added at a uniform rate over a period of one hour maintaining the temperature at 75°C and the pH at 8.2.
  • the slurry was stirred at 75oC and a pH of 8.2 for a further 30 minutes cure period.
  • Example 1A 5000 grams of the dry powder from Example 1A was blended with 1 weight percent dioctyl azelate and micronized using super heated steam at a steam to powder blend weight ratio of 3:1.
  • Example 2 Using the procedure described in Example 1 a number of antimicrobial powders were prepared.
  • Preparations 2 through 5 were conducted in a 2-liter beaker (1200 ml H 2 O) and 6 through 10 were conducted in a 4-liter beaker (2500 ml H 2 O).
  • This example describes the preparation of a TiO 2 pigment powder coated successively with Ag, copper(II) oxide (CuO), SiO 2 and hydrous alumina.
  • the product is an off white powder readily dispersible in organic polymer systems and providing them with antimicrobial properties.
  • Solutions were then prepared, consisting of 40 g Cu(NO 3 ) 2 ⁇ 3H 2 O (ACS-Alfa), in 200 ml water and 625 g of K 2 SiO 3 (Philadelphia Quartz #6 KaSil; 25 weight percent SiO 2 ), diluted to 1000 ml with water. 187.5 ml of the Cu(NO 3 ) 2 solution was added at a uniform rate to the stirred slurry over a period of one hour, maintaining the temperature at 75°C and the pH at 7.0. The temperature of the stirred slurry was increased to 90oC and the pH to 9.5 by the addition of a small amount of sodium hydroxide. The diluted K 2 SiO 3 solution was added at a uniform rate over a period of one hour maintaining the pH at 9.5 with 20% HCl and the temperature at 90oC. The slurry was kept at this pH and temperature for an additional 30 minutes.
  • Example 11A 5000 grams of the product from Example 11A were blended with 1% wt of dioctyl azelate and
  • Bactekiller ® is an inorganic antimicrobial agent composed of a zeolite base particle containing combinations of silver and copper (AC) or silver and zinc (AZ). Bactekiller ® AC and Bactekiller ® AZ
  • compositions of this invention against Klebsiella pneumoniae are provided.
  • aeruginosa Escherichia coli, Staphylococcus aureus (all bacteria), Aspergillus niger (fungus), and
  • Candida albicans were determined. The results are shown below in Table 3.
  • the fibers, having antimicrobial properties, of the present invention were evaluated.
  • the fibers were prepared as described above.
  • the activity against K. pneumoniae is shown in Table 4.
  • nylon 66 fibers were prescoured and dyed. Aliquots from the scour baths and the dye baths were analyzed. The data are presented in Table 6.
  • antimicrobial compositions of this invention retain antimicrobial activity after acid dyeing.
  • antimicrobial compositions of this invention retain antimicrobial activity after 20 washings.
  • antimicrobial TiO 2 additive does not adversely affect yarn color. Using diffuse simulated daylight

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Textile Engineering (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

An antimicrobial composition comprising an inorganic particle with a first coating providing antimicrobial properties and a second coating providing a protective function, method for preparing the same and uses; further processes for producing polymeric articles and a method for controlling microorganisms.

Description

TITLE
ANTIMICROBIAL COMPOSITIONS, PROCESS FOR
PREPARING THE SAME AND USE
BACKGROUND OF THE INVENTION FIELD OF THE INVENTION
The invention is directed to an
antimicrobial powder composition comprising inorganic particles having a primary surface coating of a metal or metal compound and a secondary coating providing a protective function such as silica and alumina or alumina, and processes for enhancing dispersibililty.
A further aspect of the invention is
directed to a polymeric article comprising at least one polymer and the aforementioned antimicrobial composition, and processes for producing said
polymeric article. The invention also is directed to bifunctional powders, which can be used to deluster fibers as well as to provide antimicrobial properties.
Another aspect of the invention is directed to a method for controlling microorganisms and various applications based on the use of the aforementioned antimicrobial materials.
DESCRIPTION OF THE RELATED ART
Polymeric articles having antimicrobial properties are described in the literature. Such articles are made in various shapes and dimensions such as granules, films, fibers, containers, pipes, structural components, medical appliances, etc. It is also known that certain metals such as silver, copper and zinc or their compounds are effective as
antimicrobial agents. Numerous attempts have been made to utilize this attribute in polymeric articles. For example, U.S. 4,906,466 describes an antimicrobial composition comprising a silver
compound, selected from AgCl, AgBr, Ag2CO3 and Ag3PO4, deposited on a physiologically inert particle,
selected from oxides of Ti, Mg, Al, Si, Ce, Hf, Nb and Ta, calcium hydroxyapatite and barium sulfate. It is disclosed that the compositions may be modified by the inclusion of other ingredients such as dispersion aids, and these compositions may be incorporated in polymeric materials in an amount of from 5-60% by weight of the composite. The antimicrobial silver compound in contact with the polymer article may interact with it producing undesirable effects, such as darkening due to reduction to metallic silver.
Several patents describe antimicrobial compositions in which zeolite particles are supports for antimicrobial metal ions. Zeolites are
aluminosilicates, of either natural or synthetic origin, which have sites at which cationic exchange may occur. By treating them with solutions of metal ions a desired antimicrobial metal ion can be
substituted in the zeolite structure. Polymer
articles having antimicrobial properties are made by incorporating the treated zeolites with the polymer or the zeolite can be mixed with the polymer and then treated with a solution of the desired antimicrobial metal ion. There are no barrier coatings on the particles to prevent interactions of the metal ions with the polymer, to control the rate of release of the antimicrobial species or to facilitate dispersion of the particles in the polymer article. For example, the use of the zeolite particles in polymer articles is described in detail in U.S. 4,775,585, and, more specifically, U.S. 4,525,410 is directed to fiber applications. Further, it is recognized that zeolite powders tend to agglomerate and are inferior in dispersibility when mixed with resins. U.S. 4,741,779 adds fine silica, dry or as a sol, to provide a zeolite powder which has high free-flowability and low agglomerating properties. Such problems as
aggregation and color development in polymer
antimicrobial zeolite compositions are also addressed in J 01164722 which relates to the use of additives such as fatty acid salts to aid dispersion and
UV-light absorbers to prevent color development.
It is most desirable that the antimicrobial additive be easily dispersible within the polymer matrix without any significant adverse effects on polymer properties. It is also desirable that the antimicrobial be effective in controlling
microorganisms at economic levels of use and remain active for months or years. Most commercially
available compositions suffer from several
deficiencies in the end use. They are often
agglomerated and therefore difficult to disperse in end use systems. In addition, in the end use systems, the antimicrobial component is in direct contact with the product matrix with which it may react, leading to deterioration in properties, development of coloring or staining and other undesirable features. The development of color occurs during the shaping
process, i.e., producing a shaped polymeric article. The cause for color deterioration may be attributed to the high metal loadings of the prior art. There is a need for antimicrobial compositions which do not have these deficiencies particularly when they are
incorporated in a polymer matrix. The composition of the present invention meets this need. SUMMARY OF THE INVENTION
One aspect of the invention relates to an antimicrobial composition comprising inorganic
particles having a first coating, i.e., primary coating of a metal or metal compound, i.e.,
antimicrobial species or component of about 0.05 to 20 % by weight of a core material. The first coating provides antimicrobial properties. A secondary coating comprises a layer of silica, silicates, borosilicates, aluminosilicates, alumina or mixtures thereof of about 0.5 to 20 % by weight of the core material. The secondary coating functions as a barrier between the antimicrobial particle and a polymer matrix in which it may be incorporated, minimizing interaction with the polymer. In the absence of such a barrier adverse interactions can occur between the polymer matrix and the antimicrobial component. This may result in undesirable coloring or staining of polymer articles and also in the deterioration of physical properties. The secondary coating layer is believed to influence the rate at which the antimicrobial component diffuses from a dispersed particle into the polymer matrix. The small residual porosity of the silica or alumina coating, for example, also allows the antimicrobial component to diffuse through at a slow controlled rate thus extending the duration of the antimicrobial activity. Further, the ability to adjust the dispersibility of the particulate compositions of this invention both increases their use efficiency and improves the quality of the product. The antimicrobial particles may further comprise a tertiary coating layer of a hydrous metal oxide, which is much less agglomerated and disperse readily in polymers. For example, a tertiary coating of hydrous alumina or magnesia will raise the isoelectric point of the composition. The control of the isoelectric point between about 5.5 and about 9.5 is beneficial in facilitating the dispersion and/or flocculation of the particulate compositions during plant processing and in their end use
applications. This both increases the use efficiency of the antimicrobial powders and improves the quality of the polymer composites. Enhanced dispersibility also can be impacted by micronizing the product with small levels, e.g., 0.1 to 1% of organic dispersion aids. Dispersion aids may be incorporated either with the antimicrobial powders or in the process for incorporating them in polymers.
A further aspect of the invention is
processes for preparing the antimicrobial composition and enhancing dispersibility comprising the steps of:
(a) forming an aqueous suspension of core material particles;
(b) depositing a first coating of the desired antimicrobial component or components on the core particle surface using suitable precipitation reactions;
(c) depositing a secondary protective silica and/or alumina coating by adding an alkali metal silicate or aluminate to the suspension and maintaining the pH between specified limits;
(d) optionally applying an additional coating of a hydrous metal oxide by treatment of the suspended particles with an appropriate salt and maintaining the pH between specified limits;
(e) recovering the solids, washing free from water soluble species and drying; and
(f) optionally adding a micronizing/dispersion aid to the dried particles prior to micronizing with superheated steam or air.
Another aspect of the invention relates to a polymeric article and processes for producing the same. Products incorporating the particulate
composition of this invention have antimicrobial properties by virtue of the particulate antimicrobial compositions that are incorporated therein. The particulate antimicrobial compositions of this
invention may be employed in a variety of products such as paints, coatings, caulks, grouts, mortar, cements and masonry products and shaped polymeric articles including, but not limited to, films, membranes, fibers, and mono-filaments including but not limited to mono-filaments for brushes. In many applications, the compositions of this invention can be used to replace all or part of fillers and/or pigments normally used in the product. For example, if TiO2 is selected as the core material, then the resulting powder, when incorporated into a fiber, will deluster the fiber as well as confer antimicrobial activity. The antimicrobial particulate compositions of this invention are particularly useful when
incorporated in a polymer carrier matrix composite. The physical properties of such composites are similar to those of the polymers themselves. Many different polymers can be used in the present invention.
Yet another aspect of the invention relates to a method for controlling microorganisms and various applications based on the use of the aforementioned antimicrobial materials. DETAILED DESCRIPTION OF THE INVENTION
Antimicrobial Composition and Preparation
The invention relates to novel particulate antimicrobial powder compositions comprising inert inorganic particles having a first coating of a metal or metal compounds and a second coating layer of silica, silicates, borosilicates, aluminosilicates, alumina or mixtures thereof.
The inorganic particles, i.e., core material may be any of the oxides of titanium, aluminum, zinc, copper; the sulfates of calcium, strontium, barium; zinc sulfide; copper sulfide; zeolites; mica; talc; kaolin; mullite or silica. Lead or mercury compounds are contemplated equivalent core material but may be undesirable due to toxicity levels. Titanium dioxide and barium sulfate are the preferred core material with titanium dioxide being most preferred. Either crystalline form, anatase or rutile titanium dioxide is suitable for use in the present invention. The average diameter of the core material is between 0.01 and 100 microns, preferably in the range 0.1 to 5 microns. In general, core materials in the sub-micron size range are preferred, since the resulting
antimicrobial composition can be distributed more uniformly throughout a polymer matrix.
The first coating conferring antimicrobial properties may be metallic silver or copper or
compounds of silver, copper and zinc which have extremely low solubility in aqueous media. The antimicrobial component may also be an alloy of silver with copper or zinc. The antimicrobial component should release silver, copper or zinc ions at an effective level of antimicrobial activity, e.g., a minimum of 2 log reduction within 24 hours in a shake flask test, over a prolonged period, such as months or preferably years. Components which meet these
criteria are silver, silver oxide, silver halides, copper, copper (I) oxide, copper (II) oxide, copper sulfide, zinc oxide, zinc sulfide, zinc silicate and mixtures thereof. Mixtures of silver with zinc silicate and silver with copper (II) oxide are
preferred. The amount of antimicrobial component on the core particle is in the range of 0.05 to 20% by weight, preferably 0.1 to 5% by weight based on the particle core material. A surprising feature of the present invention is that these powders confer
activity at loadings of the metals which are
substantially lower than those achieved by the prior art materials. This is achieved despite the use of protective coatings to encapsulate the antimicrobial components. In carrying out this invention, the core particles may also be optionally precoated with alumina in the amount of about 1 to 4 % to ensure good antimicrobial properties after precipitation of the antimicrobial components.
The secondary protective coating is selected from silica, silicates, borosilicates,
aluminosilicates, alumina, aluminum phosphate, or mixtures thereof. The secondary coating functions as a barrier between the antimicrobial particle and a polymer matrix in which it may be incorporated, minimizing interaction with the polymer. This
secondary coating also is believed to influence the rate at which the antimicrobial component diffuses from a dispersed particle into the polymer matrix.
The secondary protective coating layer corresponds to 0.5 to 20% by weight based on the core material, and preferably, e.g., 1 to 5% by weight of silica or, e.g., 1 to 6% by weight of alumina in the coated particle composition. It will be appreciated by those skilled in the art that if fine particles of a core material are employed in carrying out the invention, the practitioner should assure total surface coverage of the first coated core material. The protective layer of silica or alumina can be quite dense although it must be sufficiently porous to permit diffusion of the antimicrobial metal ions through the coating at a slow rate, while functioning as a barrier which limits interaction between the antimicrobial component and the polymeric matrix in which it is distributed. Silica is a preferred coating material because of the relative ease with which dense, uniform coatings can be obtained.
Silica-coated particles may have a low isoelectric point and may tend to be difficult to disperse in organic materials. The isoelectric point represents the pH at which a particle surface carries zero electric charge. Control of the isoelectric point between 5.5 and 9.5 is beneficial in facilitating the dispersion and/or flocculation of the particulate compositions during plant processing and in their end use applications. Therefore, for particles coated with silica or related materials with a low
isoelectric point, a tertiary coating of hydrous alumina or magnesia, or other metal oxide may be added to raise the isoelectric point. For example, hydrous oxides of Al, Mg, Zr and the rare earths, may bring the isoelectric point into the range of 5.5 to 9.5. Hydrous alumina, typically as a mixture of boehmite (A1OOH) and amorphous alumina (AI2O3 H2O), is a preferred tertiary coating material. Isoelectric points in a preferred range of 5.5 to 8.8 can readily be obtained with alumina coatings. For higher
isoelectric points, magnesia is preferred. Dispersion aids may be incorporated either with the antimicrobial powder composition or in the process for incorporating them in polymers to facilitate dispersion in end use applications.
In an alternative embodiment of the invention, alumina may be selected as the secondary protective coating and a tertiary coating may not be needed to adjust the isoelectric point. When alumina is used as the protective coating, the isoelectric point of the resulting powder typically will be in the preferred range.
The process for preparing the antimicrobial compositions of the invention comprises the steps of first forming a stirred aqueous suspension of the core material in which the concentration of solids is between 10 to about 50 weight percent. The core material employed in the process consists of fine particles of an inorganic composition selected from a group comprising the oxides of Ti, Al, Zn and Cu, the sulfates of Ca, Sr and Ba, zeolite, mica, talc, kaolin or silica. These compositions are essentially
insoluble in water or aqueous environments. Titanium dioxide and barium sulfate are the preferred core materials for use in the process of the invention with titanium dioxide being most preferred. Either
crystalline form, anatase or rutile may be used. The average particle size of the core material can extend over a wide range from 0.01 to 100 microns depending on the shape of the particle, although in most cases the range is 0.1 to 5 microns. The particles can have a wide variety of shapes, e.g. equiaxial, acicular or platelet. Smaller size equiaxial shaped particles are preferred since they give a more uniform distribution of antimicrobial effectiveness when they are
incorporated in a polymer matrix. Generally, the finely divided core material particles will exhibit a specific surface area in the range of from 0.1 to 100 m2/g. Best results are achieved when the core
material particles have a specific surface area of from 1 to 20 m2/g.
Next, the antimicrobial components are formed by precipitation reactions conducted in the stirred aqueous suspension of core material so that the core particles become coated with the precipitated antimicrobial composition. The antimicrobial
component is selected from a group comprising Ag, Ag2O, AgCl, AgBr, Agl, Cu, CuO, CU2O; CuS; ZnO; ZnS; ZnSiO3 and their combinations such as Ag/CuO,
Ag/ZnSiO3 and alloys of silver with copper or zinc. The concentrations and amounts of reactants used in applying the antimicrobial components to the core particles are such that the former amounts to between 0.05 and 20% by weight, preferably 0.1 to 5% by weight of the supporting core particle. The antimicrobial metal constituent is added to the suspension as a water soluble salt such as a nitrate or acetate together with an appropriate water soluble reagent to precipitate the desired antimicrobial compound. For example, Ag2O is an effective antimicrobial agent and it can be precipitated by adding AgNO3 to a stirred aqueous suspension of core particles while maintaining the pH in the range of 5 to 9.
Reagents used for this purpose are hydroxides of ammonia, alkali metals or alkali metal silicates. When metallic silver or copper are to be deposited on the core material, water soluble reducing agents such as formaldehyde, hydrazine or sodium nitrate are used to reduce the cation to the metal. When the antimicrobial component comprises more than one species, such as Ag and ZnSiO3, individual species may be precipitated successively or concurrently depending upon the compatibility of the reagents used to precipitate the different species. The choice of reagents, order of precipitation and procedural conditions can be employed by one skilled in the art.
The next step in the process is the application of a secondary protective coating, for example, silica or alumina to the antimicrobial particles in the aqueous suspension.
In the case of a silica coating, active silica is added to the agitated aqueous suspension heated to a temperature between 60° and 90ºC while maintaining the pH of the suspension in the range of 6 to 11. The procedure is described in detail in U.S. Patent 2,885,366 which issued on May 5, 1959 to Her, the teachings of which are incorporated herein by reference. Active silica, a low molecular weight form of silica, such as silicic acid or polysilicic acid, may be added to the suspension, or formed in situ as by the continuous reaction of an acid with an alkali silicate. Potassium silicate is generally preferred since the potassium ion has little tendency to
coagulate active silica. The bulk commodity is also more stable, which is advantageous from the standpoint of shipping and storing. The silica content of the coated composition is between 0.5 and 20% by weight and most commonly it is between 1 and 5% by weight.
During the silica deposition it is desirable to maintain substantially uniform conditions in the reaction zone to minimize precipitation of free silica gel. This is best accomplished by maintaining good agitation and introducing the reactants in a manner which does not allow local over-concentration. The pH is allowed to fall gradually to about 6 as the process is completed and the slurry is then cured to permit completion of the deposition of silica onto the surface of the antimicrobial particles. The curing step consists of holding the slurry at temperatures between 60° and 90°C, preferably between 75° and 90°C, for from about one-half to two hours, preferably about one hour, while maintaining the pH of the agitated slurry between 6 and 7.5.
Alternatively, the antimicrobial particles may be coated with alumina. This is accomplished by the addition, to the agitated aqueous suspension of the antimicrobial particles heated to between 60° and 90°C, of an alkali aluminate solution or other soluble aluminum salt, e.g., aluminate nitrate while
maintaining the pH in the range 6 to 11 by the
concurrent addition of acid or base, as required.
Sodium aluminate is preferred, because it is
commercially available as a solution, such as Vining's Solution. It is desirable to increase the density of the amorphous alumina phase in the coating by the addition of polyvalent anions selected from the group consisting of sulfate, phosphate and citrate. As in the case of the silica coating a small residual porosity is necessary to allow the antimicrobial species to diffuse through the protective coating. The alumina content of the coated composition is between 0.5 and 20% by weight and preferably between 1 and 6% by weight. The concentration of polyvalent anion in the suspension is about 0.5% by weight based on the alumina used to coat the particles.
The product is then recovered as a dry powder, consisting of particles coated with silica, alumina or silica/alumina, by filtration or
centrifugation combined with aqueous washing to remove soluble salts. A vacuum rotary-type filter is
particularly suitable since washing can be carried out without removing the product from the filter. Washing is continued until the filtrate is quite free from soluble ions. The washed cake is then dried in an air or vacuum oven. A preferred
commercial method of drying the product is spray drying. The product may be passed through a
micronizer with either heated air or superheated steam, preferably at temperatures below 350ºC.
It would be appreciated by those skilled in the art that the micronizing/dispersion aid could also be added prior to drying of the recovered and washed solids.
In carrying out the invention and enhancing dispersibility, control of the isoelectric point between 5.5 and 9.5 is beneficial. The isoelectric point of the particles can be adjusted within the range 5.5 to 8.8 by using alumina as the secondary or tertiary coating. However, it may be preferred for other reasons to use silica or other low isoelectric point material for the protective coating. In which case, a tertiary coating is desired to adjust the isoelectric point to the range of 5.5 to 9.5. The higher isoelectric point improves the dispersibility of the antimicrobial composition in all systems, e.g., water systems.
The isoelectric point represents the pH at which the surface of the particles carries zero electric charge. The isoelectric point is determined by measuring the electrophoretic mobility of the particles in a dilute suspension. An automated electrokinetics analyzer, such as the Pen Ken System 3000, manufactured by Pen Ken, Inc., Bedford Hills, N.Y. is used for this purpose. Measurements are made at different pH levels and by graphically plotting the results, the isoelectric point, i.e., the pH at which the Zeta potential is zero, can be determined. An optional hydrous metal oxide tertiary outer layer is applied as a final coating process. A solution of a salt which contains the desired metal is added to the agitated aqueous suspension at a
temperature between 60° and 90ºC, while controlling the pH of the suspension with either acid or base within the range of 6 to 11, preferably 7.0-9.0.
Metals contemplated for use according to the invention are those whose hydrous oxides have high isoelectric points, i.e. in the range of 5.5 to 9.5.
The hydrous metal oxide is selected from the group consisting of alumina, magnesia, zirconia and rare earth metal oxides, with alumina, particularly boehmite A1OOH and amorphous alumina AI2O3 H2O, and magnesia which are most preferred for reasons of ease of application, availability and economy. Sodium aluminate is a preferred source of aluminum, and magnesium chloride is a preferred source of magnesium. The use of alumina allows adjustments of the
isoelectric point up to about 8.8 while the use of a magnesium precipitate allows adjustments to up to about 9.5. When sodium aluminate is used, the pH of the suspension is preferably maintained in the range of 8 to 8.5. When magnesium chloride is used, the pH is preferably maintained at about 9. Other water soluble salts may be used according to the invention such as chlorides, nitrates, and acetates. Where an acid salt is used as a source of metal, a strong alkali, such as sodium hydroxide or potassium
hydroxide, can be added to the aqueous suspension to maintain the pH within the desired range. If a basic salt is used as the source of metal, a strong acid, such as hydrochloric acid, can be added to the aqueous suspension to maintain the pH within the desired range. Coating can be accomplished at room temperature, but the best results are obtained when the temperature of the suspension is maintained in the range of from 60° to 90ºC.
The product is recovered as a dry powder, comprising the core material having the antimicrobial agent and the hydrous metal oxide/silica or alumina coating using the procedures previously described. It has also been found to be advantageous, both from the standpoint of improving the rate of compounding antimicrobial compositions of the invention in polymer systems and of forming more uniform dispersions, to add dispersion aids to the powders. The benefit derived from the dispersion aid is greater in those powders wherein the particles have not been given a hydrous metal oxide coating. Dispersion aids which can be used effectively in this aspect of the
invention are organic esters, polyols and polyester oligomers. Dioctyl azelate is a preferred dispersion aid for the antimicrobial compositions of the
invention. The amount of dispersion aid added to the antimicrobial powder is between 0.2 and 3% by weight with 0.5 to 1% being sufficient in most cases. The dispersion aid is normally intimately mixed with the antimicrobial powder, in standard equipment such a "v" or ribbon blender, prior to the micronizing step.
Antimicrobial Polymer Articles of the Invention
and Processes for Producing the Same
A further aspect of this invention relates to polymer articles having antibacterial properties by virtue of particulate antimicrobial compositions being incorporated into the polymer matrix. The particulate antimicrobial compositions of this invention may be employed in a variety of products such as paints, coatings, caulks, grouts, mortar, cement and masonary products and shaped polymeric articles including, but not limited to, films, membranes, fibers and
mono-filament, including but not limited to
mono-filaments for brushes. The antimicrobial powders that are made by the above processes can be
incorporated as fillers or surface treatments for plastics, fibers, rubbers and other high molecular weight natural and synthetic materials. They are very effective as broad-spectrum antibacterials,
antifungals and disinfectants and they have excellent durability, due to their low solubility in water.
The organic polymers from which the articles are fabricated include synthetic, natural and semi- synthetic organic polymers. Examples of polymers that can be used to practice this invention include, but are not limited to, aliphatic and aromatic polyesters, including polyethylene terephthalate, polybutylene terephthalate, polyethylene isophthalate,
polyhexamethylene terephthalate, polylactic acid, polyglycolic acid, and liquid crystalline polymers for high performance resins and fibers; polyester block copolymers; aliphatic and aromatic polyamides
including nylon 6, nylon 66, nylon 610, nylon 11, nylon 12, nylon 1212, poly-p-phenylene
terephthalamide, poly-m-phenylene isophthalamide;
copolymerised polyamides; polyolefins including polyethylene, polypropylene, and copolymers thereof; vinyl polymers, including polystyrene,
polyacrylonitrile, polyvinylalcohol, polyvinyl
acetate, polyvinylchloride, polyvinylidene chloride, ABS resins and acrylic resins; copolymers of ethylene and vinyl acetate; fluorocarbon polymers, including polytetrafluoroethylene, polyvinylidene fluoride and polyvinyl fluoride; polyurethanes; segmented
polyurethane elastomers, spandex or elastane elastomers; polyethers, including polyacetals;
polyketones, polyetherether ketone (PEEK), polyether ketoneketone (PEKK); polyether and polyester block polymers; polysulfides; polysulfones; polysiloxanes such as polydimethyl siloxane; polycarbonates;
thermosetting synthetic polymers such as
phenol-formaldehyde copolymer, polyurethane,
polyesterurethane, polyetherurethane,
polyetherurethaneurea, polyesterurethaneurea; natural polymers such as cellulosics, cotton and wool; and regenerated or semi-synthetic polymers such as rayon, cuprammonium rayon, acetate rayon, triacetate rayon, reconstituted silk and polysaccharides. This group includes reasonable copolymers, terpolymers and blends of many of the species listed. Spandex is defined herein to refer to a fiber or filament made from a long chain synthetic polymer that comprises at least 85% by weight of a segmented polyurethane.
The polymer articles of this invention can be, for example, in the shape of films, fibers, powders, granules or articles made therefrom such as containers, pipes and monofilaments for brushes. When a high degree of antimicrobial effect is desired, the moulded article preferably has a large surface area.
A polymer article of the invention having antimicrobial properties is comprised of at least one of the aforementioned particulate antimicrobial compositions and at least one organic polymer. The antimicrobial composition accounts for 0.1 to 60% by weight, preferably 0.1 to 15% by weight of the polymer article, and most preferably 0.3 to 2% weight of the polymer article.
If the antimicrobial composition is incorporated in an amount less than about 0.1% by weight, the polymer article has insufficient antimicrobial activity for any useful applications. However, it will be appreciated by those skilled in the art that if extremely fine particles are
incorporated into the polymer matrix, then less than about 0.1% may be acceptable. Above about 60% by weight there is no significant increase in the
antimicrobial activity of the polymer article and the physical properties of the polymer article start to show some deterioration. This limits the usefulness of the article. Furthermore, the incorporation of high levels of the antimicrobial composition is undesirable from an economic standpoint and because of undesirable effects on the properties of the composite. A
preferred upper level for the antimicrobial component is about 15% weight below which level there is an optimum combination of antimicrobial activity, polymer article properties and cost-efficiency.
When a polymer article according to the present invention has a relatively large thickness, such as containers, pipes, granules or coarse fibers, the particle size of the antimicrobial powder may be in the range of a few microns to tens of microns or even up to a hundred microns. When fibers or films are molded as an article according to the present invention, preference is given to a smaller size particle, for instance, a particle size of 5 microns down to a one hundredth of a micron (ten nanometers), especially less than 2 microns, is commonly employed for fibers intended for use in clothing.
The polymer articles according to the present invention may contain other additives as well as antimicrobial compositions. They may contain, for example, polymerization catalysts, stabilizers, delustering agents, optical whitening agents, organic or inorganic pigments, inorganic fillers, plasticisers and so on. It is also possible that the antimicrobial particles themselves can fulfill a dual role and provide the benefits of some of the aforementioned additives.
In many applications, the compositions of this invention can be used to replace all or part of fillers and/or pigments normally used in the product. This invention also relates to bifunctional powders, which can be used to deluster polymeric fibers as well as to provide antimicrobial properties. For example, if TiO2 is selected as the core particle, then the resulting powder, when incorporated into a fiber, will deluster the fiber as well as confer antimicrobial activity. The antimicrobial particulate compositions of this invention are particularly useful when
incorporated in polymer matrix. The physical
properties of such composites are similar to those of the polymers themselves. Many different polymer compositions can be used in the present invention.
Conventional procedures for incorporating powders in polymer compositions may be used to prepare the polymer articles of the invention. The
antimicrobial powders may be added to a monomer or to an intermediate product prior to polymerization.
However, generally they are mixed or compounded with a finished polymer before it is shaped into a useful article. Precoating of antimicrobial particles with polymer greatly facilitates incorporation of the particles in the bulk polymer. This may be done, for example, by slurrying the antimicrobial powder with a solution of the polymer, then removing the solvent by drying. About 1 to 5% by weight of polymer based on the coated powder is suitable for this purpose.
The polymer articles are fabricated from the antimicrobial polymer compositions and mixtures of them using well known procedures. These include, but are not limited to, for example, coating, molding, extruding, spinning and melt blowing. If it is desirable to have the antimicrobial component
predominantly at the surface of the article this can be accomplished by heating the finished article to a temperature at which the surface becomes sticky or tacky and immersing it, or drawing it through a free flowing bed of antimicrobial particles or sprinkling said particles onto the heated surface.
Alternatively, a tacky surface can be produced by dipping the article in an appropriate solvent. On cooling the article the surface sets with the
antimicrobial particles embedded in it. Dispersion aids may also be incorporated in the process of forming the polymer carrier matrices or articles.
Process for Controlling Microorganisms The present invention also provides processes for controlling microorganisms using the antimicrobial materials of the invention.
Microorganisms can be controlled in a variety of media by contacting an effective amount of the antimicrobial material with a microorganism. A convenient medium is an aqueous medium although a gaseous medium would behave similarly. Contacting the skin or other parts of a mammal with an effective amount of the
antimicrobial material would also be expected to control microorganisms.
The antimicrobial material of the present invention controls a broad spectrum of microorganisms. The material has been found to be useful in
controlling bacteria, myceteae and viruses in the Shake Flask Test described, infra. The antimicrobial material would also be expected to control algae, protozoa, viroids and prions in a similar manner.
By the term "bacteria" is meant eubacteria and archaebacteria. Eubacteria include fermicutes, gracilicutes and ternicutes. Gracilicutes include gram-negative, facultatively anaerobic rods.
Gram-negative, facultatively anaerobic rods include Enterobacteriaceae. Enterobacteriaceae include
Klebsiella and Escherichia. Klebsiella include
Klebsiella pneumoniae and Escherichia include
Escherichia coli. Fermicutes include the group gram-positive cocci, and the group endospore-forming rods and cocci. Gram-positive cocci include
Micrococcaceae. Micrococcaceae include Staphylococcus and Staphylococcus includes Staphylococcus aureus.
Endospore-forming rods and cocci include Bacillaceae. Bacillaceae includes Bacillus which includes Bacillus circulans. All references herein to bacteria are in accordance with Bergey's Manual of Systematic
Bacteriology, Williams & Wilkens, 1st ed. Vol. 1-4, (1984).
The term "Myceteae" includes Amastigomycota. Amastigomycota include Deuteromycotina which includes Deuteromycetes. Deuteromycetes include Aspergillis and Candida. Aspergillis includes Aspergillis niger and Candida includes Candida albicans.
The term "virus" includes bacteriophage. Bacteriophage includes T-series bacteriophage which includes T-even bacteriophage such as bacteriophage T4.
Applications
Examples of suitable applications comprising the antimicrobial articles and materials of the present invention include medical applications, such as, melt blown antimicrobial fibers for sterile filters dental devices, food wrap, floor coverings, such as carpet backings, textile applications such aε sportswear, intimate apparel, shoe linings, socks, undergarments and the like and coatings. More
specifically, examples of medical devices include wound closure devices, such as those sutures which are generally described in "Gore-Tex" Suture Bulletins, W.L. Gore & Assoc, Inc. (1986). Examples of devices for purifying or sterilizing aqueous solutions include those which are generally described in Gelman Sciences Process Microfiltration Catalog, (April 1986).
Similarly, examples of devices for purifying or sterilizing a gas include those which are generally described in "Nonwovens in Filtration (1987)
Worldwide," Filter Media Consulting, Inc., (April 1988). Examples of catheters include those generally described in "MEDSPEC 1989," Medical Device Register, Inc., (1989). Examples of suitable devices for storing, transporting or dispensing sterile solutions, devices for controlling odors, wound dressings and garments such as gowns and masks are generally
described in "Hospital Supply Index," Product
Analysis, Vol 1A and ID, IMS America Ltd., (Third Quarter 1986). Examples of medical implants are generally described in "The Orthopedic Implants and Allied Products Markets Outside the U.S.," Frost & Sullivan, Inc., (April 1985). Examples of floor coverings, such as carpet backing, are generally described in Edwards, U.S. Patent 3,563,838,
Hendersen, U.S. Patent 3,821,062 and Peterson, U.S. Patent 3,502,538. Examples of food wraps are
generally described in Chemical Week, March 13, 1983, p. 11. Examples of coatings are generally described in Biomedical Business International, March 2, 1988, pp. 37-38 (Medical), Textil Praxis International, foreign edition with English
supplement, 1980, vol. 35, pp. XVI-XXIII (Consumer), and West Marine Products Catalog, (P.O. Box 1020
Watsonville, CA 95077) (Summer 1989) pp. 99-100
(Marine). Examples of tests in which a preservative comprising the antimicrobial material of the present invention could be used are described in "United
States Pharmacopeia, Microbiologial Tests (51)."
Antimicrobial Preservative Effectiveness, Vol. XXII pp. 1478-1479 (1990).
Preparation of Polymer Samples for Testing
For polymers which are stable in a melt and whose melt viscosity is not too high (e.g., nylon 6,6) melt spinning is the preferred method. In continuous operation, injection of the antimicrobial particulate just prior to spinning would be typical. A
particularly convenient laboratory variant of melt spinning called press melt spinning allows one to produce very small samples of fiber for evaluation. In this process the polymer is ground to a powder (typically until it will pass through a 100 mesh screen) and mixed with the dry powder additive at the desired concentration (1% by weight for example). The mixture is dried at >70ºC under vacuum overnight and is then compression molded into a cylindrical plug at the appropriate molding temperature for the type of polymer being used. The plug is removed from the mold and placed in a fiber spinning unit. Under
hydraulically applied ram pressure, the polymer plug is melted and extruded through a spinneret into filaments which can then be drawn and wound up on collection bobbins for antimicrobial testing.
If the polymer is soluble in a solvent then wet or dry spinning become alternative processes for consideration. In either process, the antimicrobial particulate is dispersed (at the desired
concentration) in the polymer solution prior to spinning. The solution is extruded through a
spinneret and recovered as fiber either by evaporation of the solvent (dry spinning) or coagulation of the polymer by a non-solvent (wet spinning). Further processing as practiced in the art such as extraction, drawing, drying, or crystallizing may be required.
Other fiber forming processes, including, but not limited to, flash spinning, dispersion
spinning, air gap spinning, and centrifugal spinning may be useful in appropriate polymer systems.
The polymeric articles evaluated in the examples of this invention were prepared as follows:
Nylon 66 - dead bright nylon 66 powder (46 HRV) was admixed with the indicated additives and melt spun into fibers.
Polyethylene - high density polyethylene (0.85 MI) was admixed with the indicated additives and flash spun from solution in difluorochloromethane to produce a plexifilamentary web for testing.
Poly-m-phenylene-isophthalamide - the indicated additives were admixed to a solution of poly-m-phenylene isophthalamide (I.V. = 1.5) in dimethylacetamide/CaCl2. This solution was then dry spun and the resultant fibers washed and drawn 4x before testing physical properties.
Polyethylene terephthalate - dead bright polyethylene terephthalate powder (21.4 HRV) was admixed with the indicated additives and melt spun into fibers.
Segmented polyurethane urea copolymer - the indicated additives were admixed to dimethylacetamide solutions of segmented polyurethane-urea copolymer containing a polyester soft segment or other soft segments. These solutions were either cast into films by solvent evaporation or wet spun into an aqueous coagulation bath to produce fibers for evaluation of antimicrobial activity.
Evaluation of the antimicrobial properties in the Examples was performed using the following test methods.
(1) Leaching Test Method for Antimicrobial Powders
Polyethylene bottles (60 ml) or sterile polystyrene centrifuge tubes (50 ml) are cleaned by rinsing with a 50/50 (V/V) nitric acid/deionized water solution. Following the nitric acid rinse, the bottles are rinsed several times with deionized water to ensure complete removal of the acid. Into these cleaned bottles are added 50 ml of either deionized water or physiological saline (0.8%). 0.2 gm of neat test sample is then added, shaken briefly by hand and the 0.4% dispersion allowed to sit at ambient
temperature for 24 hours. After the specified period, the dispersion is filtered through a sterile 0.22 micron filter containing a cellulose acetate or cellulose nitrate membrane and sterile storage bottle and cap. The aqueous leachate is then analyzed for trace metals via either Inductively Coupled
Plasma-Atomic Emission Spectroscopy (ICP-AES) or Flame Atomic Absorption (AA). Elemental analysis is reported in ppb.
(2) Scour and Dye Procedure
Samples were secured in cheese cloth and prescoured and dyed in an Ahiba laboratory atmospheric dyer (Ahiba, Inc. Type WBRG7) using standard nylon levelling acid dye procedures as described in Du Pont Technical Bulletin NY-12 (except as noted below).
Prescouring was done at 71ºC for 15 minutes using 0.25 g/1 each of Merpol DA and TSPP. Dyeing was done near the boil (99ºC) for 1 hour and at pH 6 using leveling acid dyes and no UV inhibitors. Samples were then whiz dried. Aliquots of scour and dye baths were retained for heavy metal analysis.
(3) Washing Procedure
Samples were secured in cheese cloth and washed in a Kenmore washer (Model 82110084) as
specified in AATTCC test method 150-1987 with the exception of using a different type and less amount of detergent, i.e., used 30 +/-5 g of Tide instead of 90 +/- 0.1 g of AATCC standard detergent 124. Samples were tumble dried at 68-71°C in a Kenmore dryer (Model 95018502). All samples were washed 20 times with drying after each wash.
(4) Shake Flask Test for Antimicrobial Activity
Antimicrobial activity was measured using the Shake Flask Test described generally in U.S.
Patent 4,708,870 and outlined in Malek and Speier, The Journal of Coated Fabrics, Vol. 12, July 1982, pp.
38-45.
The Shake Flask Test requires the test material to be in a form having a high surface area to weight ratio. Articles having the form of powders, fibers, and thin films have proven to be acceptable.
The bacterial inoculum for the Shake Flask Test was prepared by transferring 2.0 ml of an
overnight broth culture to a 300 ml nephyloculture flask (Bellco Glass Inc., Vineland, N.J.) containing 100 ml of Tryptic Soy Broth (TSB) (Remel, Lexena, KS). This flask was incubated at 37°C with shaking (ca. 200 rpm). Growth of the culture was determined during incubation using a Klett-Summerson photoelectric colorimeter (Klett MFg. Co., NY, NY). When the culture reached late-log phase (185-200 Klett units for Klebsiella pneumonias ATCC 4352), appropriate dilutions were made with sterile 0.2 mM phosphate buffer (pH 7).
This inoculum was then placed into sterile, disposable 250 ml Erlenmeyer flasks (Corning Glass Co., Corning, NY) containing 0.75 g of the material produced by the process of this invention or a
suitable control material as indicated below. Each flask contained a known concentration of bacteria in a final volume of 75 ml phosphate buffer.
The initial concentration of bacteria used in the various examples was determined by serial dilution of the inoculum (0.2 mM Phosphate buffer, pH 7) and plating in triplicate on Trypticase Soy Agar (TSA) plates (sold commercially by BBL, Cockeysville, MD). The flasks were shaken on a Burrell wrist action shaker (Burrell Corp., Pittsburgh, PA). A 1.2 ml aliquot was removed from each flask after shaking for 1 hour (or other appropriate time interval as
indicated). Duplicate petri plates containing TSA were inoculated via spread plating with 0.1 ml each of the sample. The remaining 1.0 ml was serial diluted and plated in duplicate. The TSA plates were
incubated at 37°C for 18 to 24 hours. Plates having between 30 and 300 colonies were counted and the bacterial concentration determined from the mean of the plate counts. If none of the plates contained at least 30 colonies, all colonies were counted and the bacterial concentration determined from the mean of the plate counts. Below the limit of detection of the procedure described herein, the colony count was said to be zero.
Antimicrobial activity was determined by the formulas:
kt = log10(Co) - log10(Ct+1)
Dt = log10(CFt) - log10(Ct+1)
where:
Co = initial concentration of bacteria (cfu/ml) in test flask at time zero
Ct = concentration of bacteria (cfu/ml) in test flask at time t (one is added to the number to avoid calculating the log of zero),
CFt = concentration of bacteria (cfu/ml) in control flask at time t, and
cfu/ml = colony forming units per milliliter.
The relationship between percent reduction and log reduction is conveniently seen by reference to the following:
% Reduction Kt Log Reduction
90 1 1
99 2 2
99.9 3 3
99.99 4 4
99.999 5 5
In all the Examples, the organic polymer was tested substantially free of fiber finish.
(5) Minimum Inhibitory Concentration (MIC) Procedure
Cultures and inocula preparation for bacteria and yeast were performed as described previously except cells were harvested by centrifugation, washed, and resuspended in saline. Aspergillus suspensions were prepared by harvesting mycelia from 12 day TSA plate cultures incubated at room temperature. Plates were flooded with 0.2 mM phosphate buffer (pH 7) containing 0.05% Tween® 80 and scraped with a sterile glass rod. This suspension was transferred to a sterile jar containing glass beads and shaken to release spores from the mycelial clumps. The contents were filtered through sterile glass wool to remove hyphal fragments. Spores were then harvested by centrifugation (19000xg), washed, and resuspended in saline. The concentration of spores was determined by plating the suspension prior to use.
Cultures were diluted and appropriate aliquots added to each saline dilution tube in the series to produce a final concentration of
approximately 1.0E+05 cfu/ml. Appropriate quantities of test sample were weighed and added to the initial test tube in the series. This was vortexed several times to ensure a homogeneous mixture and serial dilutions (10 fold) performed. The test tubes were shaken at 200 rpm at 37ºC for 24 hours. After 24 hours, a sample was removed from each tube via an inoculationg loop (1 ul volume) and streaked onto the surface of a TSA plate. Plates were incubated for 24 hours at 37°C. Antimicrobial activity was evaluated by visually determining the number of colonies in the initial streak across the agar plate. A "+" rating was assigned to plates having growth. A "-" rating represents plates without any colonies. The MIC was based upon the minimum concentration of test compound which resulted in no microbial growth on the plate.
The present invention is further described in the following examples and comparative showings which illustrate the advantages of the invention.
They should not be construed as limiting in any way the scope of the invention.
EXAMPLES 1-11
Preparation of Particulate Antimicrobial Compositions
EXAMPLE 1
This example describes the preparation of a titanium dioxide (TiO2) pigment powder coated
successively with silver (Ag), zinc silicate (ZnSiO3), silicon dioxide (SiO2) and hydrous alumina. The product was a white powder readily dispersable in organic polymer systems and providing them with antimicrobial properties.
The equipment consisted of a five gallon polyethylene container equipped with a paddle stirrer, burettes to introduce solutions of reactants and a pH probe. The container was mounted on a heating plate.
First Stage:
While stirring 12 liters of deionized water at 75°C, 5000g of pigment grade TiO2 (Du Pont R-101) was added to form a slurry containing about 415 g/1. A solution of 18.75g AgNO3 in 50 ml H2O, (J.T.Baker, Reagent Grade AgNO3), was added at a uniform rate to the slurry stirred at 75ºC over a period of 10
minutes. After stirring for an additional 5 minutes, the pH was adjusted to 9.0 by the addition of NH4OH. 10 ml of hydrazine, (Aldrich 35 weight percent in water), was diluted with 50 ml water and the solution was added to the slurry at a uniform rate over a 30 minute period, to convert the silver oxide to metallic silver. The slurry was stirred at 75ºC and a pH of about 8.5 for a further 30 minutes. Second Stage:
Solutions were then prepared, consisting of 20g ZnCl2 (J.T.Baker, Reagent Grade), in 100 ml water and 625 g K2SiO3 (Philadelphia Quartz, #6 KaSil; 25 weight percent SiO2), diluted to 1000 ml with water. 93.75 ml of the ZnCl2 solution and 250 ml of K2SiO3 solution were added concurrently at a uniform rate to the stirred slurry over a 30 minute period,
maintaining the temperature at 90ºC and the pH at 9.5. The remaining 750 ml of K2SiO3 solution was added at a uniform rate over a 30 minute period followed by maintaining the temperature at 90ºC and the pH at 9.5 for a further 30 minutes with continuous stirring to cure the silica coating.
Third Stage:
The slurry was then cooled to 75ºC and the pH adjusted to 8.2 with HCl. Next, 300 ml of Vinings solution NaAl(OH)4, (Stanbach-Vinings Corp. 0.385g AI2O3/ml), was added at a uniform rate over a period of one hour maintaining the temperature at 75°C and the pH at 8.2. The slurry was stirred at 75ºC and a pH of 8.2 for a further 30 minutes cure period.
The solids were recovered by filtration using a vacuum filter, and washed with deionized water until the washings tested chloride free. The washed solids were dried in an air oven at 120ºC overnight to recover 5248g of a free flowing white powder. The resulting powder was found by chemical anaylsis to contain 0.22 weight percent Ag, 0.37 weight percent ZnSiO3, 2.75 weight percent SiO2 and 2.2 weight percent AI2O3. The remainder was TiO2. EXAMPLE 1B
5000 grams of the dry powder from Example 1A was blended with 1 weight percent dioctyl azelate and micronized using super heated steam at a steam to powder blend weight ratio of 3:1.
EXAMPLES 2 TO 10
Using the procedure described in Example 1 a number of antimicrobial powders were prepared.
Preparations 2 through 5 were conducted in a 2-liter beaker (1200 ml H2O) and 6 through 10 were conducted in a 4-liter beaker (2500 ml H2O). The core
particles, reagents and quantities used in the first, second and third stages of the process are given in Table 1. The pH and temperature in degrees centigrade and the nominal analyses of the products are also shown in Table 1.
Figure imgf000036_0001
Figure imgf000037_0001
EXAMPLE 11A
This example describes the preparation of a TiO2 pigment powder coated successively with Ag, copper(II) oxide (CuO), SiO2 and hydrous alumina. The product is an off white powder readily dispersible in organic polymer systems and providing them with antimicrobial properties.
5000 grams of titanium dioxide particles, (R-101), were coated with Ag by the method of Example 1.
Solutions were then prepared, consisting of 40 g Cu(NO3)2·3H2O (ACS-Alfa), in 200 ml water and 625 g of K2SiO3 (Philadelphia Quartz #6 KaSil; 25 weight percent SiO2), diluted to 1000 ml with water. 187.5 ml of the Cu(NO3)2 solution was added at a uniform rate to the stirred slurry over a period of one hour, maintaining the temperature at 75°C and the pH at 7.0. The temperature of the stirred slurry was increased to 90ºC and the pH to 9.5 by the addition of a small amount of sodium hydroxide. The diluted K2SiO3 solution was added at a uniform rate over a period of one hour maintaining the pH at 9.5 with 20% HCl and the temperature at 90ºC. The slurry was kept at this pH and temperature for an additional 30 minutes.
The suspended particles in the stirred slurry were then coated with hydrous alumina and the solid product was recovered as described in Example 1 to give 5260 g of a free flowing off white powder.
EXAMPLE 11B
5000 grams of the product from Example 11A were blended with 1% wt of dioctyl azelate and
micronized as described in Example 1. Examples 12-29
Antimicrobial Activity of Antimicrobial Compositions in the Shake Flask Test
Using the above described procedure for the shake flask test, the antimicrobial compositions of the present invention were evaluated. The activity of a commercially available aluminum coated TiO2 pigment (R900), zinc oxide and barium sulfate was also
evaluated. Bactekiller® is an inorganic antimicrobial agent composed of a zeolite base particle containing combinations of silver and copper (AC) or silver and zinc (AZ). Bactekiller® AC and Bactekiller® AZ
(commercially available from Kanebo Zeolite U.S.A., Inc., NY, NY) were employed as standards. All
materials were evaluated at 7.5 mg/75mL. The results are shown in Table 2.
Figure imgf000040_0001
These data demonstrate the efficacy of the
compositions of this invention against Klebsiella pneumoniae.
Examples 30-35
The minimum concentrations of the antimicrobial compositions required to inhibit the growth of Klebsiella pneumoniae, Pseudomonas
aeruginosa, Escherichia coli, Staphylococcus aureus (all bacteria), Aspergillus niger (fungus), and
Candida albicans (yeast) were determined. The results are shown below in Table 3.
Figure imgf000041_0001
Examples 36-66
Antimicrobial Activity of Fibers and
Films Containing Antimicrobial Powders
in the Shake Flask Test
Using the above described procedure for the shake flask test, the fibers, having antimicrobial properties, of the present invention were evaluated. The fibers were prepared as described above. The activity against K. pneumoniae is shown in Table 4.
Figure imgf000041_0002
*
Figure imgf000042_0001
** after draw processing
Examples 67-97
Leaching from Fibers Containing Antimicrobial
Compositions after 24 Hours in Water
Using the above described leaching test method, the leaching of metals from the fibers, having antimicrobial properties, of the present invention was evaluated. The data are presented in Table 5.
Figure imgf000043_0001
Figure imgf000044_0001
Examples 98-113
Leaching from Fibers Containing Antimicrobial Compositions During Prescouring and Dying
Using the above described scour and dye procedure, nylon 66 fibers were prescoured and dyed. Aliquots from the scour baths and the dye baths were analyzed. The data are presented in Table 6.
Figure imgf000045_0001
These data show that leaching of heavy metals during finishing from fibers containing the antimicrobial compositions of this invention is within drinking water standards and significantly lower than that observed with the commercial standard.
Examples 114-131
Leaching from Fibers Containing Antimicrobial Compositions during Washing
Using the above described washing procedure, samples containing approximately equal amounts of 3 dpf and 6 dpf nylon 66 fibers were washed. Aliquots from the wash baths were analyzed. The data are presented in Table 7.
Figure imgf000046_0001
These data show that leaching of heavy metals during washng from fibers containing the antimicrobial compositions of this invention is within drinking water standards. Examples 132-146
Leaching from Washed Fibers
Using the above described leaching test method, Nylon 66 fibers which had been washed 20 times were evaluated. The results are presented in Table 8.
Figure imgf000047_0001
Examples 147-150
Antimicrobial Activity of Fibers
Containing Antimicrobial Powders after Dyeing
Using the above described shake flask test for antimicrobial activity, nylon 66 fibers which had been dyed were evaluated. The results are shown in Table 9.
Figure imgf000048_0001
These data show that fibers containing the
antimicrobial compositions of this invention retain antimicrobial activity after acid dyeing.
Examples 151-159
Antimicrobial Activity of Washed Fibers
Using the above described shake flask test for antimicrobial activity, nylon 66 fibers that had been washed 20 times were evaluated. The data are presented in Table 10.
Figure imgf000049_0001
These data show that fibers containing the
antimicrobial compositions of this invention retain antimicrobial activity after 20 washings.
Examples 160-162
Effect of Simulated Daylight Illumination on the Color of Fibers Containing Antimicrobial Compositions
Numerical color differences were determined for nylon 66 filament yarn to show that the
antimicrobial TiO2 additive does not adversely affect yarn color. Using diffuse simulated daylight
illumination and 8 degree reflected light detection, specular component excluded, the values shown in Table 12 were recorded. The universe of color is a
combination of three elements, value ("lightness'', ranging from dark to light), hue ("color", red, yellow, green, etc.), and chroma ("saturation", varying from dull to vivid). In three dimensional space, these color coordinates can be expressed as L* (black to white), a* (green to red), and b* (blue to yellow). Note that the combination of coordinates a* and b* determine hue and chroma [C*=sqrt(a*^2 + b*^2) ] while L* is a measure of value.
Figure imgf000050_0001
Examples 163-178
Tensile properties of representative
as-prepared yarns were measured and tabulated below. Results indicate no significant adverse effects of the antimicrobial additives of this invention on tensile properties.
Figure imgf000050_0002
Figure imgf000051_0001

Claims

1. An antimicrobial composition comprising tens of micron to submicron inorganic particles selected from the oxides of titanium, aluminium, zinc and copper, sulfates of calcium, strontium and barium, zinc sulfide, copper sulfide, zeolites, mica, talc, kaolin, mullite and silica, said inorganic particles having a primary surface coating of a metal or metal compound having antimicrobial properties, which are coated with a secondary protective layer selected from silica, silicates, borosilicates, aluminosilicates, alumina, aluminum phosphate or mixtures thereof.
2. The composition of Claim 1 wherein the metal or metal compounds comprise 0.05 to 20 % by weight based on the inorganic particles and said metal or metal compounds are selected from silver, silver oxide, silver halides, copper, copper (I) oxide, copper (II) oxide, copper sulfide, zinc oxide, zinc sulfide, zinc silicate and mixtures thereof.
3. The composition of Claim 2 wherein the inorganic particle is selected from titanium dioxide and barium sulfate and said primary surface coating is selected from the mixtures of silver with zinc
silicate and silver with copper (II) oxide.
4. The composition of Claim 3 wherein the protective coating comprises 0.5 to 20 % by weight and is selected from silica or alumina.
5. The composition of Claim 4 wherein the secondary coating is silica and further comprising a tertiary coating of hydrous oxides of alumina, magnesia, zirconia and rare earth metals to adjust the isoelectric point in the range of about 5.5 to about 9.5.
6. The composition of Claim 5 wherein the hydrous oxide is alumina comprising a mixture of boehmite alumina and amorphous alumina and the
isoelectric point is in the range of about 5.5 to about 8.8.
7. An antimicrobial composition comprising tens of micron to submicron inorganic particles selected from titanium dioxide and barium sulfate; said inorganic particles having a coating comprising a primary layer of about 0.1 to 5.0% weight based on inorganic particles selected from mixtures of silver with zinc silicate and silver with copper (II) oxide, and further comprising, a secondary protective layer which adjusts the isoelectric point of the composition in the range of about 5.5 to about 9.5.
8. In an antimicrobial, shaped polymer article, a polymeric carrier matrix comprising at least one polymer and about 0.1 % to 60 % by weight, based on the total weight of the shaped polymer article, of the antimicrobial composition of Claim 1, 2, 3, 4, 5, 6 or 7.
9. The antimicrobial, shaped polymer article of Claim 8 wherein the antimicrobial
composition comprises about 0.1 to 15 % by weight of the polymer article.
10. The antimicrobial, shaped polymer article of Claim 8 or Claim 9 wherein the polymeric carrier matrix is a fiber.
11. The antimicrobial, shaped polymer article of Claim 10 wherein the fiber is nylon 6,6.
12. The antimicrobial shaped polymer article of Claim 10 wherein the fiber is spandex or spandex polymer.
13. The antimicrobial shaped polymer article of Claim 10 wherein the fiber is polyethylene teraphthaiate.
14. The antimicrobial, shaped polymer article of Claim 10 wherein the inorganic particles are titanium dioxide and the antimicrobial
compositions accomplish delustering of the fiber.
15. A process for preparing antimicrobial powder compositions comprising the steps of:
(a) forming an aqueous suspension of inorganic particles;
(b) precipitating a layer of an antimicrobial coating on said inorganic
particles;
(c) adding an alkali metal silicate or aluminate and maintaining the pH between 5 to 9; and
(d) recovering the powder and removing soluble salts.
16. The process of Claim 15, further comprising, (e) adding a hydrous metal oxide to adjust the isoelectric point in the range of about 5.5 to about 9.5.
17. The process of Claim 15 or Claim 16, further comprising, micronizing or adding a dispersion aid then micronizing with superheated steam or air.
18. The process of Claim 17 wherein the inorganic particles are selected from the oxides of Ti, Al, Zn and Cu, the sulfates of Ca, Sr and Ba, zinc sulfide, copper sulfide, zeolite, mica, talc, kaolin or silica.
19. The process of Claim 18 wherein the anitimicrobial coating is selected from Ag, Ag2O, AgCl, AgBr, Agl, Cu, CuO, CU2O, CuS, ZnO, ZnS, ZnSiO3 and their combinations.
20. A process for producing an
antimicrobial shaped polymer articles comprising the steps of:
(a) admixing the antimicrobial compositions of Claims 1, 2, 3, 4, 5, 6 or 7 with at least one polymer; and
(b) shaping said admixture by coating, molding, extruding, spinning or melt blowing into a polymer article.
21. A process for controlling microoganisms in an appropriate media comprising contacting an effective amount of the antimicrobial composition of Claim 1, 2, 3, 4, 5, 6 or 7 with a microorganism to accomplish a controlled release of an antimicrobial agent.
22. The process of Claim 21 wherein the microorganisms are selected from a group consisting of bacteria, fungi, algae, protozoa and viruses.
PCT/US1993/000194 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use WO1994015462A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US07/742,963 US5180585A (en) 1991-08-09 1991-08-09 Antimicrobial compositions, process for preparing the same and use
JP6516449A JPH08505858A (en) 1991-08-09 1993-01-11 Antibacterial composition, production method and use thereof
EP93903055A EP0677989B1 (en) 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use
PCT/US1993/000194 WO1994015462A1 (en) 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use
DE69321139T DE69321139T2 (en) 1991-08-09 1993-01-11 ANTIMICROBIAL COMPOSITIONS, METHOD FOR THEIR PRODUCTION AND USE
AU34412/93A AU3441293A (en) 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/742,963 US5180585A (en) 1991-08-09 1991-08-09 Antimicrobial compositions, process for preparing the same and use
PCT/US1993/000194 WO1994015462A1 (en) 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use

Publications (1)

Publication Number Publication Date
WO1994015462A1 true WO1994015462A1 (en) 1994-07-21

Family

ID=26786293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/000194 WO1994015462A1 (en) 1991-08-09 1993-01-11 Antimicrobial compositions, process for preparing the same and use

Country Status (3)

Country Link
US (1) US5180585A (en)
DE (1) DE69321139T2 (en)
WO (1) WO1994015462A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804877A1 (en) * 1994-10-05 1997-11-05 Toto Ltd. Antibacterial solid, process for producing the same, and method of utilizing the same
WO2001038615A1 (en) * 1999-11-24 2001-05-31 Hahl Filaments Gmbh & Co. Kg Monofilament synthetic fiber
FR2826548A1 (en) * 2001-06-28 2003-01-03 Rhodianyl PARTICLE COMPRISING A MATRIX AND AT LEAST ONE BIOACTIVE AGENT, ITS PREPARATION METHOD AND ITS APPLICATIONS
US6709709B1 (en) 1999-02-08 2004-03-23 Gunze Limited Deodorizing fibers and process for producing the same
FR2846976A1 (en) * 2002-11-08 2004-05-14 Rhodianyl Yarns, fibers or filaments with antibacterial and antifungal properties, useful for making textile articles, comprise a thermoplastic matrix and zinc sulfide
WO2004091567A2 (en) * 2003-04-18 2004-10-28 Merck Patent Gmbh Cosmetic formulations comprising antimicrobial pigments
KR100613189B1 (en) 2004-11-15 2006-08-21 미지테크주식회사 Ag nano synthetic fiber and manufacturing method thereof
EP2016828A1 (en) * 2007-07-20 2009-01-21 Bühler PARTEC GmbH Microbicide composition, method for its manufacture and use of the same
US7858111B2 (en) 2001-04-04 2010-12-28 Trevira Gmbh Bioactive fiber products
US8075823B2 (en) 1999-07-30 2011-12-13 Guggenbichler J Peter Process for preparing antimicrobial plastic bodies having improved long-time performance
DE102012103903A1 (en) * 2012-05-03 2013-11-07 Eckart Gmbh Flaky effect pigment comprising a copper-containing coating, process for its preparation and use thereof
EP1210386B2 (en) 1999-07-30 2014-10-29 J. Peter Guggenbichler Method of producing antimicrobial synthetic bodies with improved long-term behavior
US11091624B2 (en) 2016-12-27 2021-08-17 Lotte Advanced Materials Co., Ltd. Thermoplastic resin composition and article produced therefrom

Families Citing this family (204)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0677989B1 (en) * 1991-08-09 1998-09-16 E.I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
US5503840A (en) * 1991-08-09 1996-04-02 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
JP3259853B2 (en) * 1991-10-21 2002-02-25 尚明 山本 Pest control materials
US6592702B2 (en) 1992-01-10 2003-07-15 Super Sack Mfg. Corp. Anti-static, anti-corrosion, and/or anti-microbial films, fabrics, and articles
US6585843B2 (en) 1992-01-10 2003-07-01 Super Sack Mfg. Corp. Anti-static, anti-corrosion, and/or anti-microbial films, fabrics, and articles
AU655349B2 (en) * 1992-02-17 1994-12-15 Kenji Nakamura An antibacterial porous inorganic capsule and a process for producing the same
GEP20002074B (en) * 1992-05-19 2000-05-10 Westaim Tech Inc Ca Modified Material and Method for its Production
US5681575A (en) * 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
US5688492A (en) * 1992-05-22 1997-11-18 The Boots Company Plc, Oral hygiene composition
WO1994015463A1 (en) * 1993-01-15 1994-07-21 E.I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
US5534288A (en) * 1993-03-23 1996-07-09 United States Surgical Corporation Infection-resistant surgical devices and methods of making them
US5385727A (en) * 1993-05-19 1995-01-31 Church & Dwight Co., Inc. Dentifrices containing zinc oxide particles and sodium bicarbonate
US6027803A (en) * 1993-06-11 2000-02-22 E. I. Du Pont De Nemours And Company Spandex containing barium sulfate
US5545428A (en) * 1993-10-05 1996-08-13 The Board Of Trustees Operating Michigan State University Method of preparing a suspension of particles and related methods
WO1995020878A1 (en) * 1994-02-01 1995-08-10 Theodor Krall Process for producing bactericidal/fungicidal plastic bodies
DE69521082T2 (en) * 1994-08-01 2002-03-07 Maruwa Kck Co. Ltd., Joetsu Metallic bactericidal agent
US6239048B1 (en) 1994-12-28 2001-05-29 Fibermark, Inc. Light-activated antimicrobial and antiviral materials
GB9502253D0 (en) * 1995-02-06 1995-03-29 Giltech Ltd The effects of antibacterial agents on the behaviour of mouse fibroblasts in vitro
GB2298149B (en) * 1995-02-14 1999-08-18 Hirayama Setsubi Kk An air conditioner for a clean room
GB9505083D0 (en) * 1995-03-14 1995-05-03 Johnson Matthey Plc Improvements in biocidal compositions
US5698210A (en) 1995-03-17 1997-12-16 Lee County Mosquito Control District Controlled delivery compositions and processes for treating organisms in a column of water or on land
FR2732189B1 (en) * 1995-03-27 1997-05-09 Kodak Pathe ORGANIC-INORGANIC GELS FOR DELIVERING CONTROLLED QUANTITIES OF ACTIVE COMPOUNDS IN AQUEOUS SOLUTIONS
CA2174484A1 (en) * 1995-04-20 1996-10-21 Masaki Hashimoto Cut flower preservative slurry composition
US5532291A (en) * 1995-05-16 1996-07-02 Betco Corporation Coating composition and processes therefor
US6139669A (en) * 1995-06-07 2000-10-31 Super Sack Mfg. Corp. Anti-microbial shoe linings, sock liners and socks and process for manufacture of same
US6451144B2 (en) * 1995-06-07 2002-09-17 Super Sack Mfg. Corp. Anti-microbial socks and process for manufacture of same
US5951799A (en) * 1995-06-07 1999-09-14 Super Sack Manufacturing Corp. Anti-microbial shoe lining and sock liner and process for manufacture of same
US6861570B1 (en) 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US5814094A (en) * 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US8801681B2 (en) 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US8455710B2 (en) 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US6087549A (en) * 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
WO1997015526A1 (en) * 1995-10-27 1997-05-01 E.I. Du Pont De Nemours And Company Hydrothermal process for making ultrafine metal oxide powders
US5756145A (en) * 1995-11-08 1998-05-26 Baylor College Of Medicine Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor
US6558686B1 (en) 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
US6854601B2 (en) * 1995-12-15 2005-02-15 Microban Products Company Bacteriostatic filter cartridge
GB9526395D0 (en) * 1995-12-22 1996-02-21 Procter & Gamble Cleansing compositions
US6217892B1 (en) * 1997-10-24 2001-04-17 Joseph A. King Water treatment composition
US6048338A (en) 1997-10-15 2000-04-11 Scimed Life Systems, Inc. Catheter with spiral cut transition member
US5891110A (en) * 1997-10-15 1999-04-06 Scimed Life Systems, Inc. Over-the-wire catheter with improved trackability
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
US6037057A (en) * 1998-02-13 2000-03-14 E. I. Du Pont De Nemours And Company Sheath-core polyester fiber including an antimicrobial agent
JP4979151B2 (en) * 1998-02-19 2012-07-18 アスカテック株式会社 Antibacterial / deodorizing material and method for producing the same
US6113579A (en) * 1998-03-04 2000-09-05 Scimed Life Systems, Inc. Catheter tip designs and methods for improved stent crossing
US6517515B1 (en) 1998-03-04 2003-02-11 Scimed Life Systems, Inc. Catheter having variable size guide wire lumen
US6312705B1 (en) * 1998-04-03 2001-11-06 Puritek, Inc. Iodophor compositions
US6342280B1 (en) 1998-06-23 2002-01-29 Nextec Applications, Inc. Products of and methods for improving adhesion between substrate and polymer layers
US6416613B1 (en) 1998-06-23 2002-07-09 Nextec Applications, Inc. Products of and method for improving adhesion between substrate and polymer layers
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US20020043447A1 (en) 1998-09-03 2002-04-18 John E. Barry Belt having antimicrobial action
US6248342B1 (en) 1998-09-29 2001-06-19 Agion Technologies, Llc Antibiotic high-pressure laminates
AU1133600A (en) 1998-10-29 2000-05-22 Agion Technologies, Llc Antimicrobial plastic closures for drinking containers
US6596401B1 (en) 1998-11-10 2003-07-22 C. R. Bard Inc. Silane copolymer compositions containing active agents
US6436422B1 (en) 1998-11-23 2002-08-20 Agion Technologies L.L.C. Antibiotic hydrophilic polymer coating
US6585767B1 (en) 1998-11-23 2003-07-01 Agion Technologies, Inc. Antimicrobial suturing ring for heart valve
US6296863B1 (en) 1998-11-23 2001-10-02 Agion Technologies, Llc Antimicrobial fabric and medical graft of the fabric
US6264630B1 (en) 1998-12-23 2001-07-24 Scimed Life Systems, Inc. Balloon catheter having an oscillating tip configuration
TWI276444B (en) * 1999-03-30 2007-03-21 Shiseido Co Ltd Cosmetic composition for external use
US6652751B1 (en) * 1999-04-27 2003-11-25 National Research Council Of Canada Intrinsically bacteriostatic membranes and systems for water purification
US6582715B1 (en) 1999-04-27 2003-06-24 Agion Technologies, Inc. Antimicrobial orthopedic implants
US20050191355A1 (en) * 1999-05-27 2005-09-01 Foss Manufacturing Co., Inc. Anti-microbial and antifungal fluid conduits and methods of manufacture thereof
US6723428B1 (en) * 1999-05-27 2004-04-20 Foss Manufacturing Co., Inc. Anti-microbial fiber and fibrous products
EP1066825A1 (en) * 1999-06-17 2001-01-10 The Procter & Gamble Company An anti-microbial body care product
US6383273B1 (en) 1999-08-12 2002-05-07 Apyron Technologies, Incorporated Compositions containing a biocidal compound or an adsorbent and/or catalyst compound and methods of making and using therefor
US6579469B1 (en) 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
US6267590B1 (en) 1999-11-24 2001-07-31 Agion Technologies, Llc Antimicrobial dental products
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US7179849B2 (en) * 1999-12-15 2007-02-20 C. R. Bard, Inc. Antimicrobial compositions containing colloids of oligodynamic metals
US6579539B2 (en) 1999-12-22 2003-06-17 C. R. Bard, Inc. Dual mode antimicrobial compositions
US7074482B1 (en) * 2000-02-28 2006-07-11 Unitika Fibers Ltd. Antibacterial polyamide fiber and method for producing the same
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
IL135487A (en) * 2000-04-05 2005-07-25 Cupron Corp Antimicrobial and antiviral polymeric materials and a process for preparing the same
US20050150514A1 (en) * 2000-04-05 2005-07-14 The Cupron Corporation Device for cleaning tooth and gum surfaces
US20040247653A1 (en) * 2000-04-05 2004-12-09 The Cupron Corporation Antimicrobial and antiviral polymeric materials and a process for preparing the same
US6640371B2 (en) * 2000-06-02 2003-11-04 Milliken & Company Topical incorporation of solid antimicrobial compounds on yarn surfaces through high pressure
AU2001288317A1 (en) 2000-08-30 2002-03-13 Agion Technologies, Llc Bi-laminar, hyaluronan coatings with silver-based anti-microbial properties
DE10043151A1 (en) * 2000-08-31 2002-03-28 Peter Steinruecke Bone cement with antimicrobial effectiveness
DE20020649U1 (en) * 2000-12-06 2002-04-11 stryker Trauma GmbH, 24232 Schönkirchen Device for surgical or therapeutic use, in particular implants and surgical instruments and their accessories
US6623504B2 (en) 2000-12-08 2003-09-23 Scimed Life Systems, Inc. Balloon catheter with radiopaque distal tip
US7157614B1 (en) * 2000-12-21 2007-01-02 Fountainhead, Llc Treatment devices providing targeted antimicrobial action
KR100399108B1 (en) * 2001-03-12 2003-09-22 제이티엘주식회사 Method of manufacturing a activated synthetic cottonwool
JP2002277816A (en) * 2001-03-21 2002-09-25 Minolta Co Ltd Image display device
DE10117106A1 (en) * 2001-04-06 2002-10-17 Creavis Tech & Innovation Gmbh Antimicrobial food preservation systems
WO2002087339A1 (en) * 2001-04-30 2002-11-07 Ak Properties, Inc. Antimicrobial powder coated metal sheet
US6929705B2 (en) 2001-04-30 2005-08-16 Ak Steel Corporation Antimicrobial coated metal sheet
US20030026848A1 (en) * 2001-07-06 2003-02-06 Joshi Ashok V. Beneficial materials for topical or internal use by a human or other animal
US20030031728A1 (en) * 2001-08-09 2003-02-13 Martin Daniel H. Antimicrobial polymeric tubing
EP1882482B2 (en) 2001-09-12 2022-03-30 ConvaTec Limited Antibacterial wound dressing
US7201763B2 (en) * 2001-10-24 2007-04-10 Boston Scientific Scimed, Inc. Distal balloon waist material relief and method of manufacture
EP1450866A4 (en) * 2001-12-03 2007-02-28 Bard Inc C R Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
US7357949B2 (en) * 2001-12-21 2008-04-15 Agion Technologies Inc. Encapsulated inorganic antimicrobial additive for controlled release
US20030118658A1 (en) * 2001-12-21 2003-06-26 Trogolo Jeffrey A. High aspect ratio encapsulated inorganic antimicrobial additive for controlled release
DE60302211T2 (en) * 2002-01-11 2006-07-27 Rhodianyl USE OF ZINC SULPHIDE AS ACARICIDE
US20030170543A1 (en) * 2002-02-26 2003-09-11 Alltrista Zinc Products Company, L.P. Zinc fibers, zinc anodes and methods of making zinc fibers
US7578997B2 (en) 2002-04-30 2009-08-25 Kimberly-Clark Worldwide, Inc. Metal ion modified high surface area materials for odor removal and control
US7976855B2 (en) * 2002-04-30 2011-07-12 Kimberly-Clark Worldwide, Inc. Metal ion modified high surface area materials for odor removal and control
FR2841471B1 (en) * 2002-06-28 2006-02-17 Rhodianyl ENCAPSULATION SYSTEM OF ACTIVE PRINCIPLES, METHOD OF MAKING SUCH A SYSTEM AND APPLICATIONS
BR0314210A (en) * 2002-09-10 2005-06-28 Josef Peter Guggenbichler Prof Methods for the production of an antimicrobial plastic product
US7641912B1 (en) 2003-01-13 2010-01-05 EnviroCare Corporation Antimicrobial coatings for treatment of surfaces in a building setting and method of applying same
US8282951B2 (en) 2003-01-13 2012-10-09 EnviroCare Corporation Antimicrobial coatings for treatment of surfaces in a building setting and method of applying same
US20040186528A1 (en) * 2003-03-20 2004-09-23 Medtronic, Inc. Subcutaneous implantable medical devices with anti-microbial agents for chronic release
US7303683B2 (en) * 2003-04-04 2007-12-04 The Clorox Company Microorganism-removing filter medium having high isoelectric material and low melt index binder
US20050003178A1 (en) 2003-04-21 2005-01-06 Detert James W. Apparatus and methods for the attachment of materials to polyurethane foam, and articles made using them
CA2678624C (en) * 2003-05-16 2012-11-06 Exciton Technologies Inc. Deposition products, composite materials and processes for the production thereof
US7687106B2 (en) * 2003-06-20 2010-03-30 Certainteed Corporation Algae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles, and process for producing same
US7811630B2 (en) * 2003-06-20 2010-10-12 Certainteed Corporation Algae resistant roofing granules with controlled algaecide leaching rates, algae resistant shingles, and process for producing same
EP1648605A4 (en) * 2003-06-26 2008-02-06 Scm Metal Products Inc Catalysts for the production of methylchlorosilances using zinc oxide promoters
US20040266546A1 (en) * 2003-06-27 2004-12-30 Ben Huang Antimicrobial grips for sports equipment
DE10333029A1 (en) * 2003-07-21 2005-02-17 Merck Patent Gmbh Nanoparticulate UV protectants used in cosmetic, sunscreen, dermatological or other protective uses (e.g. as textile or packaging coatings) comprise a metal oxide with a silicon dioxide coating
JP2005046294A (en) * 2003-07-28 2005-02-24 Yoshiari Kawada Waterproof medical bed sheet with antibacterial property
US7906148B2 (en) * 2003-07-31 2011-03-15 Boston Scientific Scimed, Inc. Latex medical articles for release of antimicrobial agents
US7364756B2 (en) * 2003-08-28 2008-04-29 The Cuprin Corporation Anti-virus hydrophilic polymeric material
IL157625A0 (en) * 2003-08-28 2004-03-28 Cupron Corp Anti-virus hydrophilic polymeric material
DE10340277B4 (en) * 2003-08-29 2006-11-23 Bio-Gate Bioinnovative Materials Gmbh Personal care products containing silver agglomerates
US20060259020A1 (en) * 2003-09-17 2006-11-16 Minnesota Scientific, Inc. Bacteria resistant coating for surgical instrument
US20050058682A1 (en) * 2003-09-17 2005-03-17 Minnesota Scientific, Inc. Bacteria resistant coating for surgical instrument
US8104247B2 (en) * 2003-11-12 2012-01-31 Margaret Henderson Hasse Disposable roof covering
DE10359338B4 (en) * 2003-12-17 2007-07-19 Heraeus Kulzer Gmbh Antimicrobial nanosilver additive for polymerizable dental materials
WO2005078014A1 (en) * 2004-02-18 2005-08-25 Nippon Wishborn Corporation Resin composition and, produced therewith, furniture, home appliance or molding
ES2245875B1 (en) * 2004-03-26 2006-11-16 Joaquin Espuelas Peñalva MANUFACTURING AND FILTER PROCESS OF NON-WOVEN FABRIC AND / OR FILTERING INJECTED SHEETS OR STRUCTURES OBTAINED BY SUCH PROCESS FOR FILTRATION AND ELIMINATION OF THE PNEUMOFILA LEGIONELLA.
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060006567A1 (en) * 2004-07-12 2006-01-12 Rocky Shih Method for manufacturing an anti-microbial shoe pad
DE102004040119A1 (en) * 2004-08-18 2006-04-27 Heinrich-Heine-Universität Düsseldorf Agent, useful for e.g. inactivating infectious prion and decontaminating device, instrument or appliance infected with prion, comprises a nano-particle
US20060062850A1 (en) * 2004-09-13 2006-03-23 Chen John C Controlled release antimicrobial polymer compositions
MX2007005476A (en) * 2004-11-07 2008-04-22 Cupron Corp Copper containing materials for treating wounds, burns and other skin conditions.
KR101254818B1 (en) * 2004-11-09 2013-04-15 쿠프론 인코포레이티드 Methods and materials for skin care
TWI282385B (en) * 2004-12-02 2007-06-11 Taiwan Textile Res Inst Method for producing durably anti-microbial fibers
US20060126751A1 (en) * 2004-12-10 2006-06-15 Anthony Bessios Technique for disparity bounding coding in a multi-level signaling system
US7744574B2 (en) * 2004-12-16 2010-06-29 Boston Scientific Scimed, Inc. Catheter tip to reduce wire lock
WO2006084161A2 (en) * 2005-02-03 2006-08-10 Ralph Sacks Anti-microbial granules
US20080274183A1 (en) * 2005-02-04 2008-11-06 Phillip Michael Cook Thermoplastic articles containing a medicament
KR101340750B1 (en) * 2005-03-21 2013-12-12 쿠프론 인코포레이티드 Antimicrobial and antiviral polymeric master batch, processes for producing polymeric material therefrom and products produced therefrom
US20060251807A1 (en) * 2005-05-06 2006-11-09 Hong Keith C Roofing Granules With Improved Surface Coating Coverage And Functionalities And Method For Producing Same
WO2006133410A2 (en) 2005-06-08 2006-12-14 Smaht Ceramics, Inc. Biocidal ceramic compositions, methods and articles of manufacture
ITIS20050002A1 (en) * 2005-09-01 2007-03-02 Jokero Inv Srl Photocatalytic filters coated with suspensions of titanium dioxide and other compounds and methods for obtaining said filters.
US20070142533A1 (en) * 2005-12-15 2007-06-21 Gil Sun Ok Nano-silver infused polymeric composition and methods of manufacturing the same
US9334654B2 (en) * 2005-12-22 2016-05-10 Certainteed Corporation Roofing products including mixtures of algae-resistant roofing granules
US7595107B2 (en) * 2005-12-22 2009-09-29 Certainteed Corporation Algae resistant roofing system containing silver compounds, algae resistant shingles, and process for producing same
US20070148342A1 (en) * 2005-12-23 2007-06-28 Kalkanoglu Husnu M Controlled time-release algae resistant roofing system
US8771831B2 (en) * 2005-12-23 2014-07-08 The United States Of America As Represented By The Secretary Of The Army Multi-functional yarns and fabrics having anti-microbial, anti-static and anti-odor characterisitics
KR20080102204A (en) * 2006-02-16 2008-11-24 작스트레벤 케미 게젤샤후트밋트베슈렝크테르하후트웅 Biocidal composition
JP5089055B2 (en) * 2006-02-22 2012-12-05 株式会社シナネンゼオミック Antibacterial zeolite and antibacterial composition
US8063116B2 (en) * 2006-08-25 2011-11-22 Sciessent Llc Antimicrobial powder coatings and method
US8518449B2 (en) * 2006-08-25 2013-08-27 Sciessent Llc Polymer particle coating method
US20080085326A1 (en) * 2006-10-04 2008-04-10 Hai Xiong Ruan Antimicrobial material compositions enriched with different active oxygen species
CN100535206C (en) * 2007-01-09 2009-09-02 辽宁银珠化纺集团有限公司 Process of mfg. antibiosis polyamide fibre using high speed spinning
DE102007003648A1 (en) * 2007-01-18 2008-07-24 Rebac Gmbh Copper-containing molding compound of polyester, its preparation and use
DE102007003662A1 (en) * 2007-01-18 2008-07-24 Rebac Gmbh Antimicrobial polyester molding composition, useful e.g. for producing fibers, films or shaped articles, contains monovalent copper and aromatic, aliphatic and/or cycloaliphatic polyester(s)
DE102007003649A1 (en) * 2007-01-18 2008-07-24 Rebac Gmbh Polyester-based molding material containing divalent copper, used for production of blends, powder, molded parts, film, fabric or fibres with an antimicrobial action, e.g. for medical products
US7897266B2 (en) * 2007-02-09 2011-03-01 Rovcal, Inc. Personal grooming device having a tarnish resistant, hypoallergenic and/or antimicrobial silver alloy coating thereon
US20080199646A1 (en) * 2007-02-15 2008-08-21 Medtronic Vascular, Inc. Inline Particle Deposition Extrusion
US20080302713A1 (en) * 2007-06-05 2008-12-11 Gilbert Patrick Antimicrobial filter cartridge
DE102007048107A1 (en) 2007-10-05 2009-06-04 Hunck, Wolfgang, Dipl.-Ing. Antibiotically active substrate for inoculation purposes for producing materials like e.g. dyes and papers, comprises an antibiotically active nano-particular arrangement made from a continuous metal coating with a highly porous surface
CN101952525A (en) * 2007-10-30 2011-01-19 世界矿物公司 Modified mineral-based fillers
CN101255614B (en) * 2008-03-28 2010-10-06 刘燕平 Inorganic solid-phase combination powder, master batch and manufacture method, fibre and manufacture method
US20090304762A1 (en) * 2008-06-05 2009-12-10 Bayer Materialscience Llc Antimicrobial thermoplastic molding composition
BRPI0917206B1 (en) * 2008-07-31 2018-04-17 Clarke Mosquito Control Products, Inc. METHOD FOR THE FORMATION OF A DOUBLE RELEASED TABLET, TABLETS AND METHOD FOR THE MANUFACTURE OF AN EXTENDED SOLID MATRIX
US8551517B2 (en) * 2008-12-16 2013-10-08 Kimberly-Clark Worldwide, Inc. Substrates providing multiple releases of active agents
US11052029B2 (en) 2009-06-16 2021-07-06 W. R. Grace & Co.-Conn. Cation compatible metal oxides and oral care compositions containing the metal oxides
AR079182A1 (en) * 2009-06-16 2012-01-04 Grace W R & Co CATIONICO METAL OXIDES - COMPATIBLE AND COMPOSITIONS FOR BUCODENTAL CARE CONTAINING METAL OXIDES
US9540822B2 (en) 2009-11-24 2017-01-10 Certainteed Corporation Composite nanoparticles for roofing granules, roofing shingles containing such granules, and process for producing same
CN104941004B (en) 2009-11-25 2018-09-14 扩散技术公司 The rear loading method of the plastics of zeolite is adulterated with antimicrobial metal ion pair
KR101135571B1 (en) * 2009-12-01 2012-04-17 (주)에이씨티 manufacturing method for silica powder coated by antiseptic, and composition for external skin comprising the silica powder
CN102834122B (en) 2009-12-11 2015-03-11 扩散技术公司 Method of manufacturing antimicrobial implants of polyetheretherketone
EP2571542B1 (en) 2010-05-07 2018-06-20 Difusion Technologies Inc. Medical implants with increased hydrophilicity
US20120184669A1 (en) * 2011-01-17 2012-07-19 Eastman Chemical Company Miscible Blends Comprising Copolyesters of Aromatic Dicarboxylic Acid With CHDM and Either NPG or TMCD
CN102108484B (en) * 2011-01-18 2012-07-04 厦门建霖工业有限公司 Preparation method of double-layer antimicrobial plating
TR201101244A2 (en) * 2011-02-09 2012-06-21 Gürallar Yapi Malzemeleri̇ Ve Ki̇mya Sanayi̇ A.Ş. Antimicrobial Layer Forming Method and Products Obtained by This Method
EP2713747B1 (en) 2011-05-24 2023-02-22 Agienic, Inc. Compositions and methods for antimicrobial metal nanoparticles
US20120301528A1 (en) * 2011-05-24 2012-11-29 Uhlmann Donald R Compositions and methods for antimicrobial metal nanoparticles
US9155310B2 (en) 2011-05-24 2015-10-13 Agienic, Inc. Antimicrobial compositions for use in products for petroleum extraction, personal care, wound care and other applications
EP2726555B1 (en) * 2011-06-28 2015-09-23 E. I. du Pont de Nemours and Company Treated inorganic pigments having reduced photoactivity and improved anti-microbial properties and their use in polymer compositions
AU2012275785B2 (en) 2011-06-28 2015-07-09 E. I. Du Pont De Nemours And Company Treated inorganic pigments having reduced photoactivity and improved anti-microbial properties and their use in coating compositions
CN103620116B (en) * 2011-06-28 2016-08-17 纳幕尔杜邦公司 There is the photolytic activity of reduction and the inorganic pigment processed of antimicrobial property and their purposes in paper wood serosity
CN103635542B (en) * 2011-06-28 2016-08-17 纳幕尔杜邦公司 Treated inorganic particle
EP2753341A4 (en) * 2011-09-08 2015-03-04 Nanox Tecnologia S A Antimicrobial compositions and uses thereof
US9649338B2 (en) * 2012-03-02 2017-05-16 Rowan University Use of silver-containing layers at implant surfaces
US9155311B2 (en) 2013-03-15 2015-10-13 Bunge Amorphic Solutions Llc Antimicrobial chemical compositions
KR101368253B1 (en) * 2012-07-25 2014-02-28 주식회사 지클로 method for manufacturing antimicrobial heat-retaining fiber, fiber produced thereby, and fabric using the fiber
US10208241B2 (en) 2012-11-26 2019-02-19 Agienic, Inc. Resin coated proppants with antimicrobial additives
US20160046796A1 (en) * 2014-05-01 2016-02-18 Agienic, Inc. Compositions For Use In Corrosion Protection
US11352551B2 (en) 2012-11-26 2022-06-07 Agienic, Inc. Proppant coatings containing antimicrobial agents
JP6040021B2 (en) * 2012-12-13 2016-12-07 昭和電工株式会社 Antibacterial antiviral composition and method for producing the same
WO2014115965A1 (en) * 2013-01-22 2014-07-31 (주)비에스써포트 Plastic molded product comprising copper-based compound microparticles and preparation method therefor
EP3575263B1 (en) 2013-06-25 2024-06-12 Servicios Administrativos Peñoles S.A. de C.V Method for producing a bacteriostatic and fungistatic additive in masterbatch for application in plastics
JP2016533788A (en) * 2013-06-27 2016-11-04 カルペッパー, テイラー シー.CULPEPPER, Taylor C. Antimicrobial device with highly conductive and dielectric layers
DE102013011033A1 (en) * 2013-06-29 2014-12-31 Johnson Controls Gmbh Seat cover for a motor vehicle and method for producing a seat cover
US9883759B2 (en) 2014-01-09 2018-02-06 Goverre, Inc. Closeable beverage lid
US10792398B2 (en) * 2014-02-20 2020-10-06 Becton, Dickinson And Company Antimicrobial inserts for medical devices
KR101625906B1 (en) * 2014-04-28 2016-05-31 (주)비에스써포트 Artificial biomaterial using copper based compound
US10736324B2 (en) 2015-08-14 2020-08-11 Imertech Sas Inorganic particulate containing antimicrobial metal
IT201600119819A1 (en) * 2016-11-25 2018-05-25 Thales Alenia Space Italia Spa Con Unico Socio POLYMERIC MATERIAL ANTIBACTERIAL, ITS COMPOSITE AND THEIR USES
US10730799B2 (en) 2016-12-31 2020-08-04 Certainteed Corporation Solar reflective composite granules and method of making solar reflective composite granules
KR102014366B1 (en) * 2017-07-12 2019-09-04 코오롱글로텍주식회사 Master batch for melt blown spinning
FR3085103B1 (en) * 2018-08-22 2021-01-08 Commissariat Energie Atomique NEW ANTIMICROBIAL AGENT BASED ON DOPED ZEOLITHS
US10954131B2 (en) 2018-10-03 2021-03-23 International Business Machines Corporation Biocidal janus particles
WO2020104303A1 (en) 2018-11-19 2020-05-28 Basf Se Method for preparing a functional fiber
US12016802B2 (en) 2019-10-22 2024-06-25 Aerobiotix. Llc Air treatment system for operating or patient rooms
PL433561A1 (en) 2020-04-16 2021-10-18 Centrum Badań I Rozwoju Technologii Dla Przemysłu Spółka Akcyjna Filler for producing composite materials, a composite material, method of producing a composite material and a composite material overlay
US20210352907A1 (en) * 2020-05-13 2021-11-18 Vapor Technologies, Inc. Antimicrobial cu-based topcoat
KR102402524B1 (en) * 2020-09-22 2022-05-27 엘지전자 주식회사 Refrigerator
CN114436574B (en) * 2022-02-24 2023-08-22 西安理工大学 Inactivated sterilizing high-corrosion-resistance double-fiber modified repair mortar and preparation method thereof
DE102022116274A1 (en) 2022-06-29 2024-01-04 Gehr-Kunststoff-Extrusionsgesellschaft mbH ANTIBACTERIAL THERMOPLASTIC SUBSTRATE

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885366A (en) * 1956-06-28 1959-05-05 Du Pont Product comprising a skin of dense, hydrated amorphous silica bound upon a core of another solid material and process of making same
US3785798A (en) * 1967-04-26 1974-01-15 Gaf Corp Biologically active particulate material and the process for manufacturing same
US4464317A (en) * 1980-01-28 1984-08-07 The Washington University Method of encapsulating active agents with inorganic coatings
EP0251783A2 (en) * 1986-07-03 1988-01-07 Johnson Matthey Public Limited Company Anti-microbial composition
EP0253663A2 (en) * 1986-07-16 1988-01-20 Zenji Hagiwara Polymer containing amorphous aluminosilicate particles and process for producing the same
EP0488269A1 (en) * 1990-11-28 1992-06-03 Matsushita Electric Industrial Co., Ltd. An antibacterial and antifungal composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2595290A (en) * 1946-07-25 1952-05-06 Quinn Products Inc Water purification
JPS5937956A (en) * 1982-08-24 1984-03-01 カネボウ株式会社 Particle filled fiber structure
JPS59133235A (en) * 1983-01-21 1984-07-31 Kanebo Ltd Zeolite particle-containing polymer and its production
ATE88324T1 (en) * 1984-12-28 1993-05-15 Johnson Matthey Plc ANTIMICROBIAL COMPOSITIONS.
US4741779A (en) * 1985-07-19 1988-05-03 Nippon Chemical Industrial Co. Ltd. Additives for resins and their composition
JPH0662289B2 (en) * 1985-08-23 1994-08-17 善次 萩原 Amorphous aluminosilicate filler and method for producing the same
JPH062570B2 (en) * 1985-08-23 1994-01-12 善次 萩原 Antibacterial agent
WO1990009736A1 (en) * 1989-02-28 1990-09-07 Kanebo Ltd. Antibacterial or conductive composition and applications thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885366A (en) * 1956-06-28 1959-05-05 Du Pont Product comprising a skin of dense, hydrated amorphous silica bound upon a core of another solid material and process of making same
US3785798A (en) * 1967-04-26 1974-01-15 Gaf Corp Biologically active particulate material and the process for manufacturing same
US4464317A (en) * 1980-01-28 1984-08-07 The Washington University Method of encapsulating active agents with inorganic coatings
EP0251783A2 (en) * 1986-07-03 1988-01-07 Johnson Matthey Public Limited Company Anti-microbial composition
EP0253663A2 (en) * 1986-07-16 1988-01-20 Zenji Hagiwara Polymer containing amorphous aluminosilicate particles and process for producing the same
EP0488269A1 (en) * 1990-11-28 1992-06-03 Matsushita Electric Industrial Co., Ltd. An antibacterial and antifungal composition

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804877A4 (en) * 1994-10-05 1998-04-15 Toto Ltd Antibacterial solid, process for producing the same, and method of utilizing the same
EP0804877A1 (en) * 1994-10-05 1997-11-05 Toto Ltd. Antibacterial solid, process for producing the same, and method of utilizing the same
US6709709B1 (en) 1999-02-08 2004-03-23 Gunze Limited Deodorizing fibers and process for producing the same
US8075823B2 (en) 1999-07-30 2011-12-13 Guggenbichler J Peter Process for preparing antimicrobial plastic bodies having improved long-time performance
EP1210386B2 (en) 1999-07-30 2014-10-29 J. Peter Guggenbichler Method of producing antimicrobial synthetic bodies with improved long-term behavior
WO2001038615A1 (en) * 1999-11-24 2001-05-31 Hahl Filaments Gmbh & Co. Kg Monofilament synthetic fiber
US7858111B2 (en) 2001-04-04 2010-12-28 Trevira Gmbh Bioactive fiber products
FR2826548A1 (en) * 2001-06-28 2003-01-03 Rhodianyl PARTICLE COMPRISING A MATRIX AND AT LEAST ONE BIOACTIVE AGENT, ITS PREPARATION METHOD AND ITS APPLICATIONS
WO2003001914A1 (en) * 2001-06-28 2003-01-09 Rhodianyl Particle comprising a matrix and at least one bioactive agent
AU2003292343B2 (en) * 2002-11-08 2007-08-02 Rhodianyl Articles with antibacterial and antifungal activity
FR2846976A1 (en) * 2002-11-08 2004-05-14 Rhodianyl Yarns, fibers or filaments with antibacterial and antifungal properties, useful for making textile articles, comprise a thermoplastic matrix and zinc sulfide
WO2004044284A1 (en) * 2002-11-08 2004-05-27 Rhodianyl Articles with antibacterial and antifungal activity
WO2004091567A2 (en) * 2003-04-18 2004-10-28 Merck Patent Gmbh Cosmetic formulations comprising antimicrobial pigments
WO2004091567A3 (en) * 2003-04-18 2005-01-20 Merck Patent Gmbh Cosmetic formulations comprising antimicrobial pigments
WO2004092283A3 (en) * 2003-04-18 2005-01-20 Merck Patent Gmbh Antimicrobial pigments
KR100613189B1 (en) 2004-11-15 2006-08-21 미지테크주식회사 Ag nano synthetic fiber and manufacturing method thereof
EP2016828A1 (en) * 2007-07-20 2009-01-21 Bühler PARTEC GmbH Microbicide composition, method for its manufacture and use of the same
DE102012103903A1 (en) * 2012-05-03 2013-11-07 Eckart Gmbh Flaky effect pigment comprising a copper-containing coating, process for its preparation and use thereof
US9127165B2 (en) 2012-05-03 2015-09-08 Eckart Gmbh Plate-shaped effect pigment comprising a copper-containing coating, method for the production thereof, and use thereof
US11091624B2 (en) 2016-12-27 2021-08-17 Lotte Advanced Materials Co., Ltd. Thermoplastic resin composition and article produced therefrom

Also Published As

Publication number Publication date
DE69321139T2 (en) 1999-05-12
DE69321139D1 (en) 1998-10-22
US5180585A (en) 1993-01-19

Similar Documents

Publication Publication Date Title
EP0677989B1 (en) Antimicrobial compositions, process for preparing the same and use
US5180585A (en) Antimicrobial compositions, process for preparing the same and use
US5503840A (en) Antimicrobial compositions, process for preparing the same and use
WO1994015463A1 (en) Antimicrobial compositions, process for preparing the same and use
US20100047366A1 (en) Articles with antibacterial and antifungal activity
Dural Erem et al. Antibacterial activity of PA6/ZnO nanocomposite fibers
CN102618962B (en) Antibacterial polyurethane fiber and preparation method thereof
JPS6323960A (en) High molecular material containing amorphous aluminosilicate particle and production thereof
CN111548607B (en) Preparation method of antibacterial color master batch and stock solution colored PET antibacterial functional fiber
US20100124861A1 (en) Method for the production of a bioactive cellulose fiber with a high degree of whiteness
CN103882543A (en) Anti-mite antibacterial thermoplastic polymer melt spun fiber and preparation method thereof
JP4074032B2 (en) Antibacterial polyamide fiber
JP2000119914A (en) Production of antibacterial polyamide fiber
WO2022084997A1 (en) Colorless antimicrobial composition
JP2000178870A (en) Antimicrobially processing method for textile product
KR101133113B1 (en) Antibacterial silver compound-containing synthetic fiber with high whiteness and preparation thereof
KR101756911B1 (en) Process Of Producing Sheath/Core Type Synthetic Fiber Containing Sericite
KR20160092294A (en) Process Of Producing Funtional Synthetic Fiber Containing Sericite
KR102609452B1 (en) Antibacterial melt-blown non-woven fabric and Manufacturing method thereof
JP2022096619A (en) Fiber material
WO2018111667A1 (en) Composite laundry additive
JPH0343456A (en) Antibacterial resin composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA FI HU JP KP KR LK MG MN MW NO NZ PL RO RU SD UA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993903055

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993903055

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1993903055

Country of ref document: EP